ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-909733,Interferon alpha/beta signaling,7/17,72/10899,7.515088556582045e-12,6.913881472055481e-10,3.2433540086301456e-10,MX1/OAS3/IFIT3/STAT1/IFI35/OAS2/RSAD2,7
R-HSA-913531,Interferon Signaling,8/17,200/10899,2.359206993120349e-10,1.0852352168353605e-8,5.09092035357549e-9,MX1/OAS3/IFIT3/STAT1/IFI35/OAS2/RSAD2/RIGI,8
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,5/17,80/10899,1.0843282395300832e-7,3.325273267892255e-6,1.559910800727488e-6,MX1/OAS3/STAT1/OAS2/RIGI,5
R-HSA-1169408,ISG15 antiviral mechanism,3/17,72/10899,1.7589677251163402e-4,0.004045625767767583,0.0018978335981518408,MX1/STAT1/RIGI,3
R-HSA-918233,TRAF3-dependent IRF activation pathway,2/17,15/10899,2.375979671623583e-4,0.004371802595787393,0.002050845611296145,IKBKE/RIGI,2
R-HSA-877300,Interferon gamma signaling,3/17,92/10899,3.6329645680668795e-4,0.005570545671035882,0.0026131850401884572,OAS3/STAT1/OAS2,3
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,3/17,126/10899,9.112633324660928e-4,0.011165165485140119,0.005237663442685868,STAT1/IKBKE/RIGI,3
R-HSA-933541,TRAF6 mediated IRF7 activation,2/17,30/10899,9.708839552295755e-4,0.011165165485140119,0.005237663442685868,IKBKE/RIGI,2
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,2/17,35/10899,0.0013219170037566646,0.013512929371734792,0.006339017210996871,IKBKE/RIGI,2
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,2/17,40/10899,0.0017250093626751156,0.01587008613661106,0.007444777249439973,IKBKE/RIGI,2
R-HSA-6783783,Interleukin-10 signaling,2/17,47/10899,0.0023754004412327137,0.019866985508491787,0.009319752927324522,CD80/CXCL2,2
R-HSA-9705683,SARS-CoV-2-host interactions,3/17,202/10899,0.0035209644441273097,0.026316753139656594,0.012345387628443024,STAT1/IKBKE/RIGI,3
R-HSA-380108,Chemokine receptors bind chemokines,2/17,59/10899,0.0037186716392993016,0.026316753139656594,0.012345387628443024,CXCL2/CXCL3,2
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,2/17,82/10899,0.0070674981086249694,0.04644355899953551,0.021787024244633364,IKBKE/RIGI,2
R-HSA-9692914,SARS-CoV-1-host interactions,2/17,95/10899,0.009389798709089342,0.05759076541574797,0.02701626295246758,IKBKE/RIGI,2
R-HSA-9694516,SARS-CoV-2 Infection,3/17,298/10899,0.01035370614671812,0.05953381034362919,0.02792776000101598,STAT1/IKBKE/RIGI,3
R-HSA-9020958,Interleukin-21 signaling,1/17,10/10899,0.015495088690561931,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-1059683,Interleukin-6 signaling,1/17,11/10899,0.017032106184570406,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-4755510,SUMOylation of immune response proteins,1/17,11/10899,0.017032106184570406,0.0656981377613568,0.030819492542512913,IKBKE,1
R-HSA-9020956,Interleukin-27 signaling,1/17,11/10899,0.017032106184570406,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,2/17,134/10899,0.0180840572775828,0.0656981377613568,0.030819492542512913,CRTAM/SLAMF7,2
R-HSA-389359,CD28 dependent Vav1 pathway,1/17,12/10899,0.01856686501951388,0.0656981377613568,0.030819492542512913,CD80,1
R-HSA-8984722,Interleukin-35 Signalling,1/17,12/10899,0.01856686501951388,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,1/17,12/10899,0.01856686501951388,0.0656981377613568,0.030819492542512913,IKBKE,1
R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",1/17,12/10899,0.01856686501951388,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,1/17,12/10899,0.01856686501951388,0.0656981377613568,0.030819492542512913,STAT1,1
R-HSA-9678108,SARS-CoV-1 Infection,2/17,141/10899,0.01990279560079643,0.06604078158129154,0.03098022934591479,IKBKE/RIGI,2
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/17,13/10899,0.020099368307349597,0.06604078158129154,0.03098022934591479,RIGI,1
R-HSA-877312,Regulation of IFNG signaling,1/17,14/10899,0.021629619156033342,0.06861810215017475,0.03218926988738174,STAT1,1
R-HSA-9679506,SARS-CoV Infections,3/17,413/10899,0.024734218510150015,0.07585160343112672,0.03558255996197019,STAT1/IKBKE/RIGI,3
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/17,18/10899,0.027728160178560723,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-936964,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,1/17,18/10899,0.027728160178560723,0.07675414090180643,0.03600594710496641,IKBKE,1
R-HSA-9669938,Signaling by KIT in disease,1/17,20/10899,0.030763996568408225,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",1/17,20/10899,0.030763996568408225,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-9671555,Signaling by PDGFR in disease,1/17,20/10899,0.030763996568408225,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-389513,CTLA4 inhibitory signaling,1/17,21/10899,0.0322785670306146,0.07675414090180643,0.03600594710496641,CD80,1
R-HSA-622312,Inflammasomes,1/17,21/10899,0.0322785670306146,0.07675414090180643,0.03600594710496641,AIM2,1
R-HSA-389357,CD28 dependent PI3K/Akt signaling,1/17,22/10899,0.03379090977380983,0.07675414090180643,0.03600594710496641,CD80,1
R-HSA-449147,Signaling by Interleukins,3/17,473/10899,0.03509770360806629,0.07675414090180643,0.03600594710496641,CD80/STAT1/CXCL2,3
R-HSA-6783589,Interleukin-6 family signaling,1/17,24/10899,0.036808924387818354,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-982772,Growth hormone receptor signaling,1/17,24/10899,0.036808924387818354,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-8854691,Interleukin-20 family signaling,1/17,25/10899,0.03831460239107365,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,1/17,25/10899,0.03831460239107365,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-933542,TRAF6 mediated NF-kB activation,1/17,25/10899,0.03831460239107365,0.07675414090180643,0.03600594710496641,RIGI,1
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,1/17,25/10899,0.03831460239107365,0.07675414090180643,0.03600594710496641,STAT1,1
R-HSA-375276,Peptide ligand-binding receptors,2/17,201/10899,0.03837707045090322,0.07675414090180643,0.03600594710496641,CXCL2/CXCL3,2
R-HSA-912694,Regulation of IFNA/IFNB signaling,1/17,26/10899,0.039818064940214115,0.07794174413829145,0.036563060751372424,STAT1,1
R-HSA-186763,Downstream signal transduction,1/17,29/10899,0.04431519040687715,0.08429007186144816,0.03954110922562213,STAT1,1
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,1/17,30/10899,0.04580982166383052,0.08429007186144816,0.03954110922562213,STAT1,1
R-HSA-9674555,Signaling by CSF3 (G-CSF),1/17,30/10899,0.04580982166383052,0.08429007186144816,0.03954110922562213,STAT1,1
R-HSA-1839124,FGFR1 mutant receptor activation,1/17,31/10899,0.04730225270916255,0.0853295539067246,0.04002873810269689,STAT1,1
R-HSA-389356,CD28 co-stimulation,1/17,33/10899,0.05028052630796831,0.0889578542371747,0.04173080118677532,CD80,1
R-HSA-5655302,Signaling by FGFR1 in disease,1/17,38/10899,0.05768791869400436,0.10013751924242266,0.04697526646383671,STAT1,1
R-HSA-5689896,Ovarian tumor domain proteases,1/17,39/10899,0.05916285704058433,0.10079597866173626,0.04728415474978474,RIGI,1
R-HSA-1433557,Signaling by SCF-KIT,1/17,43/10899,0.06504091020937819,0.1087957043502326,0.05103688648008623,STAT1,1
R-HSA-451927,Interleukin-2 family signaling,1/17,44/10899,0.06650501342662596,0.10925823634374264,0.051253863731046324,STAT1,1
R-HSA-9012852,Signaling by NOTCH3,1/17,49/10899,0.07379321832695118,0.11910484361542997,0.05587298155872573,STAT1,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/17,51/10899,0.07669347724341324,0.1216517225240348,0.057067741687476276,STAT1,1
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/17,57/10899,0.08534305428915778,0.12876618967838935,0.06040519195439317,AIM2,1
R-HSA-447115,Interleukin-12 family signaling,1/17,57/10899,0.08534305428915778,0.12876618967838935,0.06040519195439317,STAT1,1
R-HSA-418594,G alpha (i) signalling events,2/17,318/10899,0.08655874262403855,0.12876618967838935,0.06040519195439317,CXCL2/CXCL3,2
R-HSA-186797,Signaling by PDGF,1/17,58/10899,0.08677721478326239,0.12876618967838935,0.06040519195439317,STAT1,1
R-HSA-1226099,Signaling by FGFR in disease,1/17,63/10899,0.0939163260739263,0.1349396986186075,0.06330123161742456,STAT1,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),2/17,335/10899,0.09461420865607278,0.1349396986186075,0.06330123161742456,CXCL2/CXCL3,2
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,1/17,64/10899,0.09533783054575529,0.1349396986186075,0.06330123161742456,AIM2,1
R-HSA-388841,Costimulation by the CD28 family,1/17,69/10899,0.1024139240275318,0.1427588031898928,0.06696923261768427,CD80,1
R-HSA-8939902,Regulation of RUNX2 expression and activity,1/17,73/10899,0.10803725791994279,0.14834966759156323,0.06959194932785003,STAT1,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/17,78/10899,0.11501980177778848,0.155615025934655,0.07300018379085647,CD80,1
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",1/17,85/10899,0.12470897382553503,0.16627863176738003,0.07800256181307302,SLC47A1,1
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/17,93/10899,0.13566003607931743,0.17829604741853147,0.0836400222443912,STAT1,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/17,433/10899,0.1448409409659508,0.18768121927982356,0.0880426772365305,CD80/STAT1,2
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/17,104/10899,0.15050732720948723,0.18938180840414334,0.08884043643672629,CD80,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/17,105/10899,0.15184511094616537,0.18938180840414334,0.08884043643672629,IKBKE,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/17,106/10899,0.15318091167934234,0.18938180840414334,0.08884043643672629,CD80,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/17,108/10899,0.15584657515545075,0.18938180840414334,0.08884043643672629,STAT1,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/17,110/10899,0.15850433964259825,0.18938180840414334,0.08884043643672629,IKBKE,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/17,110/10899,0.15850433964259825,0.18938180840414334,0.08884043643672629,IKBKE,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/17,113/10899,0.16247622376408677,0.1903593863057086,0.08929902561251776,CD80,1
R-HSA-500792,GPCR ligand binding,2/17,467/10899,0.1634607773712063,0.1903593863057086,0.08929902561251776,CXCL2/CXCL3,2
R-HSA-8878166,Transcriptional regulation by RUNX2,1/17,121/10899,0.1729818278258659,0.19700204733842794,0.09241514806493757,STAT1,1
R-HSA-9006936,Signaling by TGFB family members,1/17,122/10899,0.17428627289238696,0.19700204733842794,0.09241514806493757,STAT1,1
R-HSA-2132295,MHC class II antigen presentation,1/17,123/10899,0.1755887813233814,0.19700204733842794,0.09241514806493757,LAG3,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/17,146/10899,0.2050181199996427,0.22724900048153168,0.10660422219385352,IKBKE,1
R-HSA-168898,Toll-like Receptor Cascades,1/17,168/10899,0.2322403364206752,0.2543584636988348,0.11932147610586069,IKBKE,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/17,182/10899,0.24910415137724073,0.2696186109024252,0.12648012639587455,IKBKE,1
R-HSA-2990846,SUMOylation,1/17,188/10899,0.2562242422867058,0.2741003522136853,0.12858254508879974,IKBKE,1
R-HSA-5689880,Ub-specific processing proteases,1/17,220/10899,0.29313720998678083,0.3099841760779751,0.1454159178397824,RIGI,1
R-HSA-157118,Signaling by NOTCH,1/17,236/10899,0.3109403825868754,0.32507403634082427,0.15249468523997478,STAT1,1
R-HSA-425407,SLC-mediated transmembrane transport,1/17,250/10899,0.32617113347304183,0.3371656660620208,0.1581669600519777,SLC47A1,1
R-HSA-1257604,PIP3 activates AKT signaling,1/17,267/10899,0.34423968655093873,0.3518894573631818,0.16507400173787706,CD80,1
R-HSA-5688426,Deubiquitination,1/17,298/10899,0.37602010100036865,0.3801521900223507,0.17833226305396316,RIGI,1
R-HSA-9006925,Intracellular signaling by second messengers,1/17,309/10899,0.38694429064007685,0.38694429064007685,0.18151848874420082,CD80,1
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,8/16,200/4383,1.537279422350914e-7,1.5372794223509139e-6,6.472755462530164e-7,MX1/OAS3/IFIT3/STAT1/IFI35/OAS2/RSAD2/SLAMF7,8
HALLMARK_INTERFERON_ALPHA_RESPONSE,HALLMARK_INTERFERON_ALPHA_RESPONSE,6/16,97/4383,6.737847898968475e-7,3.3689239494842373e-6,1.418494294519679e-6,MX1/LAMP3/IFIT3/SAMD9/IFI35/RSAD2,6
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,3/16,200/4383,0.03377588545303263,0.06504562036827488,0.027387629628747315,CD80/CRTAM/STAT1,3
HALLMARK_KRAS_SIGNALING_DN,HALLMARK_KRAS_SIGNALING_DN,3/16,200/4383,0.03377588545303263,0.06504562036827488,0.027387629628747315,MX1/CD80/RSAD2,3
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,3/16,200/4383,0.03377588545303263,0.06504562036827488,0.027387629628747315,CD80/CXCL2/CXCL3,3
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,2/16,87/4383,0.039027372220964925,0.06504562036827488,0.027387629628747315,STAT1/CXCL3,2
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/16,158/4383,0.44481444882458987,0.5269659326717924,0.2218803927039126,CXCL2,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/16,200/4383,0.5269659326717924,0.5269659326717924,0.2218803927039126,ZNF185,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/16,200/4383,0.5269659326717924,0.5269659326717924,0.2218803927039126,LAMP3,1
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,1/16,200/4383,0.5269659326717924,0.5269659326717924,0.2218803927039126,ADAMDEC1,1
HECKER_IFNB1_TARGETS,HECKER_IFNB1_TARGETS,10/22,95/21728,9.70707041336604e-19,7.260888669197798e-16,3.5865070685173476e-16,STAP1/MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/IFI35/OAS2/RSAD2,10
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,9/22,78/21728,2.943076717174275e-17,1.1007106922231789e-14,5.436946988043003e-15,MX1/CD80/LAMP3/OAS3/IFIT3/IFI35/OAS2/RSAD2/SLAMF7,9
DAUER_STAT3_TARGETS_DN,DAUER_STAT3_TARGETS_DN,8/22,48/21728,9.583860654925029e-17,2.3895759232946407e-14,1.1803281017118193e-14,MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/IFI35/OAS2,8
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,11/22,339/21728,6.866752905815214e-15,1.284082793387445e-12,6.342711236687211e-13,MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/IFI35/OAS2/RSAD2/CXCL2/CXCL3,11
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,9/22,188/21728,1.0120813098653328e-13,1.514073639558538e-11,7.478748205531196e-12,MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/IFI35/OAS2/RSAD2,9
MOSERLE_IFNA_RESPONSE,MOSERLE_IFNA_RESPONSE,6/22,31/21728,3.70265012636867e-13,4.615970490872942e-11,2.280052972553339e-11,MX1/IFIT3/SAMD9/STAT1/OAS2/RSAD2,6
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,7/22,71/21728,4.814460653852973e-13,5.144595098688606e-11,2.5411664503795393e-11,MX1/OAS3/IFIT3/STAT1/IFI35/OAS2/RSAD2,7
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,8/22,178/21728,5.021894158556882e-12,4.609503628448835e-10,2.276858673776444e-10,MX1/LAMP3/OAS3/IFIT3/STAT1/OAS2/RSAD2/SLAMF7,8
BOWIE_RESPONSE_TO_TAMOXIFEN,BOWIE_RESPONSE_TO_TAMOXIFEN,5/22,18/21728,5.546194205352876e-12,4.609503628448835e-10,2.276858673776444e-10,MX1/IFIT3/STAT1/IFI35/OAS2,5
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,8/22,184/21728,6.559021983434988e-12,4.906148443609371e-10,2.423386017037559e-10,MX1/OAS3/IFIT3/SAMD9/STAT1/IFI35/OAS2/RSAD2,8
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,8/22,204/21728,1.503071975034342e-11,1.0220889430233525e-9,5.048595820450278e-10,MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/OAS2/RSAD2,8
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,6/22,67/21728,4.9056371837875246e-11,2.9892211863295877e-9,1.4765221452317553e-9,MX1/IFIT3/STAT1/IFI35/OAS2/RSAD2,6
EINAV_INTERFERON_SIGNATURE_IN_CANCER,EINAV_INTERFERON_SIGNATURE_IN_CANCER,5/22,27/21728,5.19517051100062e-11,2.9892211863295877e-9,1.4765221452317553e-9,MX1/IFIT3/STAT1/IFI35/OAS2,5
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,5/22,29/21728,7.632202015429026e-11,4.077776505386365e-9,2.0142127123425475e-9,MX1/IFIT3/STAT1/IFI35/OAS2,5
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,8/22,286/21728,2.2271479723290666e-10,1.1106044555347612e-8,5.485817110789491e-9,MX1/LAMP3/OAS3/IFIT3/SAMD9/STAT1/RSAD2/CXCL2,8
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,7/22,173/21728,2.769247236389682e-10,1.2946230830121764e-8,6.3947748682419635e-9,STAP1/MX1/LAMP3/OAS3/IFIT3/SAMD9/OAS2,7
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,8/22,303/21728,3.519781426697626e-10,1.5487038277469555e-8,7.649803596104439e-9,STAP1/MX1/LAMP3/IFIT3/STAT1/OAS2/RSAD2/ADAMDEC1,8
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,7/22,194/21728,6.179503564379159e-10,2.5679270367531174e-8,1.2684244158462485e-8,MX1/OAS3/IFIT3/SAMD9/STAT1/OAS2/RSAD2,7
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,7/22,203/21728,8.483361431899595e-10,3.3397654479267886e-8,1.649673054070226e-8,MX1/OAS3/IFIT3/STAT1/IFI35/OAS2/RSAD2,7
FARMER_BREAST_CANCER_CLUSTER_1,FARMER_BREAST_CANCER_CLUSTER_1,5/22,48/21728,1.086906279352456e-9,4.0650294847781855e-8,2.007916337119537e-8,MX1/OAS3/IFIT3/OAS2/RSAD2,5
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,5/22,51/21728,1.4881770645641982e-9,5.3007449728286684e-8,2.6182964895340032e-8,MX1/OAS3/SAMD9/STAT1/IFI35,5
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,4/22,17/21728,1.8590863810144986e-9,6.320893695449295e-8,3.122197702086551e-8,MX1/IFIT3/STAT1/IFI35,4
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,6/22,126/21728,2.332285400661697e-9,7.584997737804128e-8,3.7466003461430466e-8,MX1/OAS3/STAT1/OAS2/CXCL2/CXCL3,6
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,5/22,58/21728,2.889624007025706e-9,9.005994821896783e-8,4.448500116079047e-8,MX1/IFIT3/STAT1/OAS2/CXCL2,5
UROSEVIC_RESPONSE_TO_IMIQUIMOD,UROSEVIC_RESPONSE_TO_IMIQUIMOD,4/22,19/21728,3.0236418845262796e-9,9.046736518502629e-8,4.4686244272367334e-8,MX1/STAT1/IFI35/OAS2,4
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,8/22,402/21728,3.264965432586272e-9,9.393054398363582e-8,4.639687719991018e-8,MX1/LAMP3/OAS3/IFIT3/STAT1/IFI35/OAS2/AIM2,8
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,5/22,60/21728,3.439702526313675e-9,9.529249961787513e-8,4.7069613517976605e-8,MX1/SAMD9/STAT1/IFI35/OAS2,5
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,5/22,68/21728,6.530981271322619e-9,1.744704996767614e-7,8.61794897080541e-8,LAG3/MX1/STAT1/CXCL2/CXCL3,5
WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,4/22,23/21728,6.889426276057295e-9,1.7769968463761575e-7,8.777454166592053e-8,MX1/IFIT3/STAT1/IFI35,4
ZHANG_INTERFERON_RESPONSE,ZHANG_INTERFERON_RESPONSE,4/22,24/21728,8.261830339978895e-9,2.0361026721580525e-7,1.0057304220763811e-7,MX1/OAS3/STAT1/OAS2,4
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,6/22,156/21728,8.438393427392998e-9,2.0361026721580525e-7,1.0057304220763811e-7,MX1/OAS3/IFIT3/STAT1/OAS2/RSAD2,6
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,5/22,74/21728,1.0053070048088183e-8,2.3499051237406128e-7,1.1607327588417607e-7,MX1/IFIT3/STAT1/IFI35/OAS2,5
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,7/22,308/21728,1.5267442271453882e-8,3.460620248196213e-7,1.7093691346986643e-7,MX1/IFIT3/SAMD9/IFI35/OAS2/AIM2/IKBKE,7
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,5/22,83/21728,1.801339498212766e-8,3.962946896068085e-7,1.9574927674076807e-7,MX1/OAS3/OAS2/CXCL2/CXCL3,5
WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,4/22,31/21728,2.435106139532786e-8,5.204169692487211e-7,2.570593248048144e-7,OAS3/STAT1/OAS2/IKBKE,4
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,4/22,33/21728,3.1626393572452564e-8,6.571261775609588e-7,3.24586670875171e-7,OAS3/STAT1/OAS2/IKBKE,4
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,5/22,103/21728,5.360667697220076e-8,1.0837241723028695e-6,5.353042280865567e-7,MX1/IFIT3/STAT1/IFI35/OAS2,5
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,7/22,378/21728,6.213549753429361e-8,1.2230882146224113e-6,6.041429261644614e-7,MX1/OAS3/IFIT3/SAMD9/AIM2/CXCL2/CXCL3,7
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,6/22,219/21728,6.383706723462659e-8,1.2243622126025816e-6,6.047722159069888e-7,MX1/IFIT3/STAT1/IFI35/OAS2/RSAD2,6
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,4/22,40/21728,7.030662181949179e-8,1.3147338280244964e-6,6.494111647010952e-7,MX1/IFIT3/STAT1/IFI35,4
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,7/22,422/21728,1.3150288832030498e-7,2.3991258649655636e-6,1.1850452837080115e-6,CD80/CRTAM/LAMP3/STAT1/ADAMDEC1/SLAMF7/CXCL3,7
ZHAN_MULTIPLE_MYELOMA_HP_UP,ZHAN_MULTIPLE_MYELOMA_HP_UP,4/22,50/21728,1.7599913409010008e-7,3.134460769033211e-6,1.54826305928885e-6,LAG3/LAMP3/OAS2/RSAD2,4
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,7/22,453/21728,2.1265810568459046e-7,3.6992619314435733e-6,1.8272459019655142e-6,MX1/OAS3/IFIT3/SAMD9/OAS2/RSAD2/AIM2,7
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,5/22,138/21728,2.3198633215282394e-7,3.943767646598007e-6,1.948019200613426e-6,MX1/OAS3/STAT1/OAS2/IKBKE,5
TSAI_DNAJB4_TARGETS_UP,TSAI_DNAJB4_TARGETS_UP,3/22,13/21728,2.559700863707028e-7,4.254791657895238e-6,2.10164913020156e-6,OAS3/IFIT3/STAT1,3
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,5/22,144/21728,2.867574039040157e-7,4.614126189882297e-6,2.2791419823370195e-6,OAS3/IFI35/OAS2/CXCL2/IKBKE,5
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,6/22,283/21728,2.899250413428716e-7,4.614126189882297e-6,2.2791419823370195e-6,MX1/LAMP3/IFIT3/STAT1/ADAMDEC1/SLAMF7,6
ROETH_TERT_TARGETS_UP,ROETH_TERT_TARGETS_UP,3/22,14/21728,3.2556643710799873e-7,5.073410311599647e-6,2.5060048119497272e-6,MX1/IFIT3/RSAD2,3
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,6/22,321/21728,6.065272540840824e-7,9.258824205201911e-6,4.5733848804191825e-6,ZNF185/CRTAM/STAT1/RSAD2/CXCL3/RNASE4,6
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,4/22,75/21728,9.135871442001714e-7,1.3427853510717084e-5,6.632671801662957e-6,MX1/IFIT3/SAMD9/OAS2,4
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,5/22,182/21728,9.155354666398012e-7,1.3427853510717084e-5,6.632671801662957e-6,MX1/IFIT3/STAT1/IFI35/RSAD2,5
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,4/22,76/21728,9.637022842650673e-7,1.3862486704428276e-5,6.847358335567584e-6,MX1/STAT1/IFI35/OAS2,4
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,4/22,82/21728,1.308579817481918e-6,1.8468258556159898e-5,9.12237370280344e-6,MX1/OAS3/STAT1/OAS2,4
YAN_ESCAPE_FROM_ANOIKIS,YAN_ESCAPE_FROM_ANOIKIS,3/22,23/21728,1.5746804898244369e-6,2.1812240859049604e-5,1.0774129667219831e-5,MX1/STAT1/RSAD2,3
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,5/22,221/21728,2.3793655895192855e-6,3.235937201746228e-5,1.598387218988075e-5,MX1/STAT1/OAS2/CXCL2/CXCL3,5
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,6/22,409/21728,2.478574146316529e-6,3.310666895437078e-5,1.6352998596938e-5,CD80/OAS3/IFIT3/OAS2/CXCL2/CXCL3,6
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,6/22,412/21728,2.5854170590525266e-6,3.3452894320698786e-5,1.6524016192745956e-5,CRTAM/STAT1/RSAD2/ADAMDEC1/SLAMF7/CXCL3,6
XU_AKT1_TARGETS_6HR,XU_AKT1_TARGETS_6HR,3/22,27/21728,2.593941003476644e-6,3.3452894320698786e-5,1.6524016192745956e-5,MX1/OAS3/IFIT3,3
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,3/22,33/21728,4.819468597079526e-6,6.110105950195738e-5,3.0180793533896764e-5,OAS3/RSAD2/CXCL3,3
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,4/22,118/21728,5.605710267887862e-6,6.988452133966868e-5,3.451937375488841e-5,IFIT3/STAT1/IFI35/CXCL2,4
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,3/22,40/21728,8.687353550065368e-6,1.0652689271227697e-4,5.2618828232492575e-5,STAT1/IFI35/RSAD2,3
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,5/22,300/21728,1.054008746321603e-5,1.271610552013805e-4,6.281104753121947e-5,IFIT3/STAT1/IFI35/OAS2/CXCL2,5
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,5/22,309/21728,1.2158803125541763e-5,1.4436166250643236e-4,7.130726645054568e-5,LAMP3/IFIT3/RSAD2/CXCL2/CXCL3,5
RADAEVA_RESPONSE_TO_IFNA1_UP,RADAEVA_RESPONSE_TO_IFNA1_UP,3/22,47/21728,1.4192319066739989e-5,1.6587272909252362e-4,8.193263145437066e-5,MX1/STAT1/IFI35,3
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,4/22,163/21728,2.009456206901355e-5,2.3124203734803284e-4,1.1422172123439282e-4,IFI35/OAS2/RSAD2/IKBKE,4
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,3/22,53/21728,2.042327443952258e-5,2.3146377698125592e-4,1.1433124925474364e-4,IFIT3/RSAD2/CXCL2,3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,3/22,63/21728,3.4394547327034446e-5,3.783400205973789e-4,1.868805899657754e-4,ZNF185/CXCL2/CXCL3,3
WORSCHECH_TUMOR_REJECTION_UP,WORSCHECH_TUMOR_REJECTION_UP,3/22,63/21728,3.4394547327034446e-5,3.783400205973789e-4,1.868805899657754e-4,MX1/CXCL2/CXCL3,3
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,3/22,69/21728,4.52013450691769e-5,4.900087842281786e-4,2.4203923904318983e-4,IFIT3/STAT1/CXCL2,3
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,3/22,71/21728,4.9244121256878654e-5,5.187972211288061e-4,2.5625925220406834e-4,IFIT3/STAT1/IFI35,3
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,3/22,71/21728,4.9244121256878654e-5,5.187972211288061e-4,2.5625925220406834e-4,STAT1/OAS2/RSAD2,3
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,3/22,77/21728,6.277773279474018e-5,6.402375403542327e-4,3.162445492039624e-4,STAT1/CXCL2/CXCL3,3
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,5/22,437/21728,6.384441191197987e-5,6.402375403542327e-4,3.162445492039624e-4,ZNF185/STAT1/IFI35/OAS2/CXCL2,5
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,2/22,12/21728,6.419494054353938e-5,6.402375403542327e-4,3.162445492039624e-4,STAT1/OAS2,2
SOUCEK_MYC_TARGETS,SOUCEK_MYC_TARGETS,2/22,12/21728,6.419494054353938e-5,6.402375403542327e-4,3.162445492039624e-4,CXCL2/CXCL3,2
GRANDVAUX_IRF3_TARGETS_UP,GRANDVAUX_IRF3_TARGETS_UP,2/22,13/21728,7.582020789938844e-5,7.365391624512019e-4,3.6381261753500125e-4,IFIT3/OAS2,2
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,2/22,13/21728,7.582020789938844e-5,7.365391624512019e-4,3.6381261753500125e-4,STAT1/IKBKE,2
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,4/22,230/21728,7.7023375102158e-5,7.386344176463358e-4,3.6484756627338003e-4,IFIT3/STAT1/IFI35/CXCL3,4
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,3/22,84/21728,8.1398743511213e-5,7.707121537517383e-4,3.8069232474931063e-4,MX1/IFIT3/CXCL2,3
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,2/22,14/21728,8.840264814310176e-5,8.265647601380014e-4,4.082806512924832e-4,MX1/IFI35,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,4/22,250/21728,1.0631965593413231e-4,9.818160819596415e-4,4.849668516293755e-4,ZNF185/CD80/LAMP3/RNASE4,4
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,3/22,93/21728,1.1020356176464907e-4,0.001005271514633628,4.96552633881795e-4,OAS3/STAT1/OAS2,3
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,4/22,254/21728,1.1303146500323203e-4,0.0010186450099086452,5.031584554994856e-4,LAG3/STAP1/IFI35/RSAD2,4
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,4/22,262/21728,1.273726574110747e-4,0.001134223187422427,5.602481547780353e-4,LAG3/LAMP3/OAS3/IKBKE,4
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,3/22,102/21728,1.4495799900878805e-4,0.001275630391277335,6.300960699948557e-4,CD80/STAT1/IKBKE,3
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,2/22,18/21728,1.4826870113925019e-4,0.0012895928889785945,6.369928286398632e-4,CD80/RNASE4,2
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,3/22,104/21728,1.5354012317849426e-4,0.0013200920935346402,6.520578733896126e-4,CD80/STAT1/IKBKE,3
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,2/22,19/21728,1.6561044856162676e-4,0.0013918720845404137,6.875135120654168e-4,CXCL2/CXCL3,2
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,2/22,19/21728,1.6561044856162676e-4,0.0013918720845404137,6.875135120654168e-4,MX1/OAS3,2
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,3/22,108/21728,1.716823278479397e-4,0.0014268709025584323,7.048011353757524e-4,CXCL2/CXCL3/RNASE4,3
DAZARD_UV_RESPONSE_CLUSTER_G28,DAZARD_UV_RESPONSE_CLUSTER_G28,2/22,20/21728,1.83898762259055e-4,0.0015116074084590453,7.466566287209752e-4,CXCL2/CXCL3,2
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,4/22,292/21728,1.930948404508994e-4,0.001569945007144269,7.754724141677997e-4,LAMP3/RSAD2/AIM2/ADAMDEC1,4
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,2/22,22/21728,2.233080522557605e-4,0.001796069065454934,8.871661159227159e-4,CXCL2/CXCL3,2
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,4/22,314/21728,2.5482037109667997e-4,0.0020277195487267727,0.0010015895885211051,OAS3/IFIT3/STAT1/IFI35,4
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,2/22,24/21728,2.6648252183796256e-4,0.0020981992245767997,0.0010364029381177268,CXCL2/CXCL3,2
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,2/22,26/21728,3.1340815870518034e-4,0.0024167969351698445,0.0011937738872004155,MX1/STAT1,2
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,2/22,26/21728,3.1340815870518034e-4,0.0024167969351698445,0.0011937738872004155,CXCL2/CXCL3,2
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,4/22,333/21728,3.186258976111458e-4,0.0024319609327871127,0.001201264125257918,MX1/IFIT3/IFI35/RSAD2,4
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,4/22,341/21728,3.4865457178718433e-4,0.002634278986836504,0.001301198880354085,CD80/LAMP3/ADAMDEC1/SLAMF7,4
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,2/22,28/21728,3.640709874659542e-4,0.0027232509862453375,0.0013451464905321045,MX1/STAT1,2
DAZARD_UV_RESPONSE_CLUSTER_G2,DAZARD_UV_RESPONSE_CLUSTER_G2,2/22,30/21728,4.184570695561089e-4,0.003099068198296727,0.0015307809423053072,CXCL2/CXCL3,2
WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,2/22,31/21728,4.4704198484827706e-4,0.003278307888887365,0.0016193161680262667,STAT1/IKBKE,2
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,2/22,33/21728,5.069868924836245e-4,0.0036818077240558366,0.0018186244175958325,CXCL2/CXCL3,2
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,3/22,157/21728,5.152512390973927e-4,0.0037058454504312476,0.0018304978231091582,OAS2/CXCL2/CXCL3,3
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,4/22,385/21728,5.512970571517932e-4,0.003927335226186108,0.0019399024266694678,MX1/OAS3/CXCL2/CXCL3,4
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,3/22,168/21728,6.275759837424793e-4,0.004428555055088439,0.0021874793475035775,STAT1/OAS2/AIM2,3
SHIN_B_CELL_LYMPHOMA_CLUSTER_8,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,2/22,37/21728,6.379285999541885e-4,0.0044595382501470375,0.002202783458769505,CD80/STAT1,2
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,4/22,412/21728,7.108430232956835e-4,0.004923246124307141,0.002431831395485233,MX1/IFIT3/SAMD9/CXCL2,4
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,3/22,176/21728,7.18382618939788e-4,0.004929818339146435,0.002435077732958625,MX1/LAMP3/SAMD9,3
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,2/22,41/21728,7.835142771836269e-4,0.005327897084848663,0.002631708242023474,MX1/OAS2,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,4/22,428/21728,8.195439471693682e-4,0.005522692544889075,0.0027279272210189495,MX1/CXCL2/CXCL3/RNASE4,4
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,3/22,187/21728,8.563514581417259e-4,0.005719204381160812,0.002824994001952498,AIM2/CXCL2/CXCL3,3
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,3/22,189/21728,8.831163979358617e-4,0.005845761642973668,0.002887506806478691,STAT1/CXCL2/CXCL3,3
REACTOME_INTERLEUKIN_10_SIGNALING,REACTOME_INTERLEUKIN_10_SIGNALING,2/22,46/21728,9.859223069728553e-4,0.006469034084348208,0.0031953714658123017,CD80/CXCL2,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,4/22,456/21728,0.0010373766950373701,0.00670530972455049,0.0033120795290138222,IFIT3/SAMD9/CXCL2/CXCL3,4
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,3/22,200/21728,0.0010398608663741403,0.00670530972455049,0.0033120795290138222,IFIT3/STAT1/IFI35,3
HALMOS_CEBPA_TARGETS_UP,HALMOS_CEBPA_TARGETS_UP,2/22,48/21728,0.0010731964698851978,0.006861119311744684,0.003389041483847993,CXCL2/CXCL3,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,2/22,49/21728,0.0011181791016033594,0.0070881183728755326,0.0035011673921746577,CD80/LAMP3,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,3/22,207/21728,0.001148224812137961,0.007217413104867183,0.003565032366744134,LAG3/STAT1/AIM2,3
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,2/22,50/21728,0.0011640565081169588,0.007255952233929043,0.0035840687223601102,IFIT3/RSAD2,2
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,4/22,473/21728,0.0011879875810151133,0.007343923228093427,0.003627521887223182,ZNF185/OAS3/CXCL2/CXCL3,4
PID_KIT_PATHWAY,PID_KIT_PATHWAY,2/22,52/21728,0.0012584888828548145,0.007715981019470503,0.003811299377757031,STAP1/STAT1,2
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,2/22,54/21728,0.0013564800911442542,0.008117176865407217,0.004009469574666385,MX1/RNASE4,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,2/22,54/21728,0.0013564800911442542,0.008117176865407217,0.004009469574666385,CXCL2/RNASE4,2
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,2/22,54/21728,0.0013564800911442542,0.008117176865407217,0.004009469574666385,STAP1/LAMP3,2
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,2/22,55/21728,0.0014068060479830683,0.00835151526897885,0.00412522074220599,AIM2/IKBKE,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,3/22,223/21728,0.0014221132060538175,0.008375910851403587,0.004137270910276751,IFIT3/CXCL2/CXCL3,3
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,3/22,224/21728,0.001440474159454573,0.008417770869312662,0.004157947614872986,OAS2/CXCL2/CXCL3,3
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,2/22,56/21728,0.0014580166658099023,0.00845423617074269,0.004175959605869243,CXCL2/CXCL3,2
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,2/22,58/21728,0.0015630851753759866,0.008993751624471061,0.004442452603700173,CXCL2/CXCL3,2
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,2/22,59/21728,0.0016169397181525957,0.009232602360138486,0.004560432632153967,CXCL2/CXCL3,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,2/22,61/21728,0.0017272810239498861,0.00978792580238269,0.004834733966558293,STAT1/CXCL2,2
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,3/22,240/21728,0.001754829857765679,0.009869268673749834,0.004874913178280597,ZNF185/RSAD2/RNASE4,3
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,3/22,242/21728,0.001796899459070543,0.01003045369690124,0.004954530323124593,LAMP3/IFI35/CXCL3,3
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,2/22,63/21728,0.0018411208416235256,0.010201173255810348,0.005038857040232807,CXCL2/CXCL3,2
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/22,64/21728,0.0018993485325477133,0.010446416929012423,0.005159994852354855,CXCL2/CXCL3,2
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,2/22,73/21728,0.002462333093225482,0.01334655908501928,0.006592516519619712,STAT1/IFI35,2
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,2/22,73/21728,0.002462333093225482,0.01334655908501928,0.006592516519619712,CXCL2/CXCL3,2
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,2/22,74/21728,0.0025291828493845905,0.01361027893050125,0.006722780614418715,AIM2/IKBKE,2
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,2/22,76/21728,0.002665440207917223,0.014241066253729163,0.007034357240443198,CXCL2/CXCL3,2
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,2/22,78/21728,0.0028050971326873844,0.014880940817377047,0.0073504224977474575,RSAD2/CXCL3,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/22,79/21728,0.0028761963548078794,0.015103043241360034,0.007460129718149975,CXCL3/IKBKE,2
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,3/22,286/21728,0.0028873465020247124,0.015103043241360034,0.007460129718149975,LAG3/MX1/RNASE4,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,2/22,80/21728,0.0029481405797109703,0.015313952455720875,0.007564308066363674,IFIT3/STAT1,2
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,2/22,84/21728,0.0032443350382916833,0.016736293852704684,0.008266871858006395,CXCL2/CXCL3,2
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,2/22,86/21728,0.0033974601353578965,0.01740616562498429,0.008597754199788189,CD80/CXCL2,2
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,2/22,87/21728,0.0034752739990520274,0.01768370715163889,0.008734845497080283,CD80/STAT1,2
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,2/22,89/21728,0.0036333963070298353,0.01824013716549206,0.009009693421176065,IFIT3/STAT1,2
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,2/22,89/21728,0.0036333963070298353,0.01824013716549206,0.009009693421176065,CD80/STAT1,2
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,3/22,317/21728,0.0038566994422606373,0.019232074552073042,0.009499659678831466,LAMP3/STAT1/RNASE4,3
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,2/22,94/21728,0.004043178916868172,0.02002846244912181,0.009893034505547078,CXCL2/CXCL3,2
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,2/22,100/21728,0.004561988849453458,0.02244978723283676,0.011089044917992825,CXCL2/CXCL3,2
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,2/22,104/21728,0.004924109881442243,0.02407342608705097,0.011891039342182507,RSAD2/CXCL2,2
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,2/22,105/21728,0.005016656628366309,0.024209413922696772,0.011958210367107466,CXCL2/CXCL3,2
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,2/22,105/21728,0.005016656628366309,0.024209413922696772,0.011958210367107466,CXCL2/CXCL3,2
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,2/22,107/21728,0.005204158900330716,0.024953274727226766,0.012325639500783275,MX1/OAS2,2
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,3/22,359/21728,0.005455971795167225,0.02582953735939927,0.012758468355121224,STAT1/IFI35/RNASE4,3
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,3/22,359/21728,0.005455971795167225,0.02582953735939927,0.012758468355121224,MX1/LAMP3/IFIT3,3
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,2/22,125/21728,0.007034241026850898,0.03288507680052795,0.01624354342384648,STAT1/OAS2,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/22,125/21728,0.007034241026850898,0.03288507680052795,0.01624354342384648,CXCL2/CXCL3,2
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,2/22,126/21728,0.007143333399632838,0.033187660763511574,0.01639300440190341,MX1/OAS2,2
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,2/22,128/21728,0.00736382940600841,0.03400089133144624,0.016794698645282338,CXCL2/CXCL3,2
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,2/22,129/21728,0.0074752299901146065,0.034303509402489114,0.016944176470973373,IFI35/IKBKE,2
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,2/22,130/21728,0.007587396931933083,0.03449237694923877,0.01703746736445653,CXCL2/CXCL3,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,3/22,405/21728,0.007608612562332082,0.03449237694923877,0.01703746736445653,IFIT3/RSAD2/RNASE4,3
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,2/22,131/21728,0.007700328711854078,0.034697866725703914,0.01713896878795676,STAT1/IKBKE,2
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,3/22,414/21728,0.00808084514307427,0.03619444411388954,0.017878201356565197,MX1/AIM2/CXCL2,3
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,3/22,425/21728,0.00868124670430083,0.03865221746914893,0.019092215496300698,MX1/OAS3/IFIT3,3
SABATES_COLORECTAL_ADENOMA_UP,SABATES_COLORECTAL_ADENOMA_UP,2/22,140/21728,0.008750882722799823,0.038731717613338865,0.019131484495189897,CXCL2/CXCL3,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,2/22,141/21728,0.008871379754948784,0.039034070921774654,0.019280831541715317,IFI35/RNASE4,2
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,2/22,144/21728,0.009237354415663259,0.040406673116468526,0.019958826715283495,STAT1/CXCL2,2
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,2/22,146/21728,0.009485058899944165,0.04124897707650137,0.02037488172509426,MX1/STAT1,2
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,3/22,440/21728,0.009541602880437402,0.04125502285876981,0.0203778680318438,SAMD9/IFI35/AIM2,3
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,2/22,150/21728,0.00998934562005736,0.04204282845075484,0.020767003639480645,CD80/STAT1,2
CLAUS_PGR_POSITIVE_MENINGIOMA_UP,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,1/22,10/21728,0.01008125328711118,0.04204282845075484,0.020767003639480645,SLC47A1,1
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,1/22,10/21728,0.01008125328711118,0.04204282845075484,0.020767003639480645,SLC47A1,1
REACTOME_INTERLEUKIN_21_SIGNALING,REACTOME_INTERLEUKIN_21_SIGNALING,1/22,10/21728,0.01008125328711118,0.04204282845075484,0.020767003639480645,STAT1,1
SHIRAISHI_PLZF_TARGETS_UP,SHIRAISHI_PLZF_TARGETS_UP,1/22,10/21728,0.01008125328711118,0.04204282845075484,0.020767003639480645,OAS3,1
WP_TYPE_III_INTERFERON_SIGNALING,WP_TYPE_III_INTERFERON_SIGNALING,1/22,10/21728,0.01008125328711118,0.04204282845075484,0.020767003639480645,STAT1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,2/22,151/21728,0.010117258183336725,0.04204282845075484,0.020767003639480645,CXCL2/CXCL3,2
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,3/22,454/21728,0.010388434638844429,0.042931210551688574,0.021205818890575136,CD80/CXCL2/CXCL3,3
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/22,154/21728,0.010505390352108927,0.04317599990866745,0.021326732293754966,STAT1/IKBKE,2
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,3/22,463/21728,0.010955398781548213,0.044100272679304095,0.021783275697207623,CD80/STAT1/CXCL2,3
REACTOME_INTERLEUKIN_27_SIGNALING,REACTOME_INTERLEUKIN_27_SIGNALING,1/22,11/21728,0.011084025753621884,0.044100272679304095,0.021783275697207623,STAT1,1
REACTOME_INTERLEUKIN_6_SIGNALING,REACTOME_INTERLEUKIN_6_SIGNALING,1/22,11/21728,0.011084025753621884,0.044100272679304095,0.021783275697207623,STAT1,1
REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,1/22,11/21728,0.011084025753621884,0.044100272679304095,0.021783275697207623,IKBKE,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/22,11/21728,0.011084025753621884,0.044100272679304095,0.021783275697207623,MX1,1
YEMELYANOV_GR_TARGETS_DN,YEMELYANOV_GR_TARGETS_DN,1/22,11/21728,0.011084025753621884,0.044100272679304095,0.021783275697207623,STAT1,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,2/22,164/21728,0.011846325637667974,0.045428139492455395,0.022439173883833163,CXCL2/CXCL3,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/22,164/21728,0.011846325637667974,0.045428139492455395,0.022439173883833163,CXCL2/CXCL3,2
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,2/22,165/21728,0.01198437224351255,0.045428139492455395,0.022439173883833163,CD80/RNASE4,2
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,2/22,165/21728,0.01198437224351255,0.045428139492455395,0.022439173883833163,STAT1/CXCL3,2
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,CXCL2,1
HEDVAT_ELF4_TARGETS_UP,HEDVAT_ELF4_TARGETS_UP,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,CXCL2,1
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,CD80,1
REACTOME_INTERLEUKIN_35_SIGNALLING,REACTOME_INTERLEUKIN_35_SIGNALLING,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,STAT1,1
REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,STAT1,1
REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,IKBKE,1
WP_IL10_ANTIINFLAMMATORY_SIGNALING_PATHWAY,WP_IL10_ANTIINFLAMMATORY_SIGNALING_PATHWAY,1/22,12/21728,0.012085828554810996,0.045428139492455395,0.022439173883833163,STAT1,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,2/22,167/21728,0.012262602787748841,0.045862134426180666,0.022653545149999177,OAS3/STAT1,2
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,3/22,484/21728,0.012347732471794177,0.04595076561642808,0.02269732441790917,STAP1/LAMP3/CXCL2,3
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,3/22,485/21728,0.012416474570084967,0.04597783652684929,0.022710696060968337,STAT1/IFI35/RNASE4,3
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,2/22,170/21728,0.012685270256015327,0.04674178399753431,0.023088046978798963,CXCL2/CXCL3,2
BIOCARTA_IL10_PATHWAY,BIOCARTA_IL10_PATHWAY,1/22,13/21728,0.013086662583719932,0.04706165198376207,0.023246045378976198,STAT1,1
GILMORE_CORE_NFKB_PATHWAY,GILMORE_CORE_NFKB_PATHWAY,1/22,13/21728,0.013086662583719932,0.04706165198376207,0.023246045378976198,IKBKE,1
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,1/22,13/21728,0.013086662583719932,0.04706165198376207,0.023246045378976198,IKBKE,1
RUAN_RESPONSE_TO_TNF_UP,RUAN_RESPONSE_TO_TNF_UP,1/22,13/21728,0.013086662583719932,0.04706165198376207,0.023246045378976198,STAT1,1
WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1/22,13/21728,0.013086662583719932,0.04706165198376207,0.023246045378976198,CD80,1
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,2/22,174/21728,0.013258700134302486,0.04722622714503933,0.023327337078396855,CXCL2/CXCL3,2
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,2/22,174/21728,0.013258700134302486,0.04722622714503933,0.023327337078396855,OAS3/IFI35,2
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1/22,14/21728,0.01408652873261107,0.04923702566351907,0.024320568544744146,CD80,1
BIOCARTA_BLYMPHOCYTE_PATHWAY,BIOCARTA_BLYMPHOCYTE_PATHWAY,1/22,14/21728,0.01408652873261107,0.04923702566351907,0.024320568544744146,CD80,1
REACTOME_REGULATION_OF_IFNG_SIGNALING,REACTOME_REGULATION_OF_IFNG_SIGNALING,1/22,14/21728,0.01408652873261107,0.04923702566351907,0.024320568544744146,STAT1,1
WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,1/22,14/21728,0.01408652873261107,0.04923702566351907,0.024320568544744146,CD80,1
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,2/22,182/21728,0.014439067348740247,0.050234522683059085,0.02481328097629291,SAMD9/STAT1,2
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,2/22,186/21728,0.015045822562400201,0.05105837133002737,0.025220220006810595,STAP1/RSAD2,2
BIOCARTA_ASBCELL_PATHWAY,BIOCARTA_ASBCELL_PATHWAY,1/22,15/21728,0.015085427892962633,0.05105837133002737,0.025220220006810595,CD80,1
LEE_SP4_THYMOCYTE,LEE_SP4_THYMOCYTE,1/22,15/21728,0.015085427892962633,0.05105837133002737,0.025220220006810595,RSAD2,1
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,1/22,15/21728,0.015085427892962633,0.05105837133002737,0.025220220006810595,IKBKE,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/22,15/21728,0.015085427892962633,0.05105837133002737,0.025220220006810595,CD80,1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,1/22,15/21728,0.015085427892962633,0.05105837133002737,0.025220220006810595,STAT1,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2/22,191/21728,0.015819622345203038,0.05330215096491834,0.026328532210366365,CRTAM/SLAMF7,2
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,1/22,16/21728,0.016083360955476245,0.053947775760969645,0.026647437787926182,CXCL3,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,2/22,198/21728,0.016931292284526618,0.05653135376076868,0.027923592977807218,CXCL2/CXCL3,2
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON,1/22,17/21728,0.01708032881007182,0.05653135376076868,0.027923592977807218,IKBKE,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,1/22,17/21728,0.01708032881007182,0.05653135376076868,0.027923592977807218,STAT1,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,2/22,201/21728,0.01741774294195156,0.05739414854880954,0.02834976940702526,STAP1/LAMP3,2
BIOCARTA_CHEMICAL_PATHWAY,BIOCARTA_CHEMICAL_PATHWAY,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,STAT1,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,STAT1,1
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,CXCL2,1
ONDER_CDH1_TARGETS_3_UP,ONDER_CDH1_TARGETS_3_UP,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,RNASE4,1
REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,STAT1,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1/22,18/21728,0.018076332345891455,0.05803045748809789,0.02866407342854258,CXCL2,1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,1/22,19/21728,0.019071372451298862,0.06048045921147727,0.029874248780225893,STAT1,1
WP_IL9_SIGNALING_PATHWAY,WP_IL9_SIGNALING_PATHWAY,1/22,19/21728,0.019071372451298862,0.06048045921147727,0.029874248780225893,STAT1,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,2/22,211/21728,0.01908207001859443,0.06048045921147727,0.029874248780225893,ZNF185/SLC47A1,2
REACTOME_SIGNALING_BY_KIT_IN_DISEASE,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1/22,20/21728,0.020065450013879604,0.06253731920992477,0.03089023225820939,STAT1,1
REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,1/22,20/21728,0.020065450013879604,0.06253731920992477,0.03089023225820939,STAT1,1
SEIDEN_MET_SIGNALING,SEIDEN_MET_SIGNALING,1/22,20/21728,0.020065450013879604,0.06253731920992477,0.03089023225820939,RNASE4,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,1/22,20/21728,0.020065450013879604,0.06253731920992477,0.03089023225820939,ZNF185,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,2/22,222/21728,0.020987664537264413,0.06403173702638859,0.031628398109009845,CXCL2/CXCL3,2
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,1/22,21/21728,0.021058565920443306,0.06403173702638859,0.031628398109009845,STAT1,1
OUYANG_PROSTATE_CANCER_PROGRESSION_UP,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,1/22,21/21728,0.021058565920443306,0.06403173702638859,0.031628398109009845,STAT1,1
REACTOME_CTLA4_INHIBITORY_SIGNALING,REACTOME_CTLA4_INHIBITORY_SIGNALING,1/22,21/21728,0.021058565920443306,0.06403173702638859,0.031628398109009845,CD80,1
REACTOME_INFLAMMASOMES,REACTOME_INFLAMMASOMES,1/22,21/21728,0.021058565920443306,0.06403173702638859,0.031628398109009845,AIM2,1
SU_THYMUS,SU_THYMUS,1/22,21/21728,0.021058565920443306,0.06403173702638859,0.031628398109009845,ADAMDEC1,1
BIOCARTA_CTLA4_PATHWAY,BIOCARTA_CTLA4_PATHWAY,1/22,22/21728,0.022050721057024103,0.06547820811687242,0.032342880733214494,CD80,1
MURATA_VIRULENCE_OF_H_PILORI,MURATA_VIRULENCE_OF_H_PILORI,1/22,22/21728,0.022050721057024103,0.06547820811687242,0.032342880733214494,AIM2,1
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,1/22,22/21728,0.022050721057024103,0.06547820811687242,0.032342880733214494,CD80,1
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,1/22,22/21728,0.022050721057024103,0.06547820811687242,0.032342880733214494,CD80,1
WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,1/22,22/21728,0.022050721057024103,0.06547820811687242,0.032342880733214494,IKBKE,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,2/22,228/21728,0.022059503269320654,0.06547820811687242,0.032342880733214494,ZNF185/SLC47A1,2
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,2/22,229/21728,0.022240340092703068,0.0657540489697308,0.032479131984767116,IFIT3/RNASE4,2
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/22,23/21728,0.023041916308877863,0.0673255992150025,0.03325539730434264,STAT1,1
HINATA_NFKB_TARGETS_KERATINOCYTE_DN,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,1/22,23/21728,0.023041916308877863,0.0673255992150025,0.03325539730434264,ZNF185,1
ONO_FOXP3_TARGETS_UP,ONO_FOXP3_TARGETS_UP,1/22,23/21728,0.023041916308877863,0.0673255992150025,0.03325539730434264,SLAMF7,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/22,238/21728,0.023895800812631703,0.06809109892138414,0.03363351494709517,ZNF185/LAMP3,2
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/22,238/21728,0.023895800812631703,0.06809109892138414,0.03363351494709517,STAP1/CXCL2,2
BIOCARTA_TPO_PATHWAY,BIOCARTA_TPO_PATHWAY,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,STAT1,1
ONO_AML1_TARGETS_UP,ONO_AML1_TARGETS_UP,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,SLAMF7,1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,STAT1,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,STAT1,1
RUAN_RESPONSE_TO_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TROGLITAZONE_UP,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,STAT1,1
ZHAN_MULTIPLE_MYELOMA_SPIKED,ZHAN_MULTIPLE_MYELOMA_SPIKED,1/22,24/21728,0.024032152560488518,0.06809109892138414,0.03363351494709517,IFIT3,1
REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,1/22,25/21728,0.02502143069556373,0.06983593343388682,0.03449537381831449,STAT1,1
REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/22,25/21728,0.02502143069556373,0.06983593343388682,0.03449537381831449,STAT1,1
STEGER_ADIPOGENESIS_DN,STEGER_ADIPOGENESIS_DN,1/22,25/21728,0.02502143069556373,0.06983593343388682,0.03449537381831449,RNASE4,1
WP_IL7_SIGNALING_PATHWAY,WP_IL7_SIGNALING_PATHWAY,1/22,25/21728,0.02502143069556373,0.06983593343388682,0.03449537381831449,STAT1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,2/22,247/21728,0.025600859816400895,0.06993818768031464,0.03454588217814585,CRTAM/CXCL2,2
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
HAHTOLA_CTCL_CUTANEOUS,HAHTOLA_CTCL_CUTANEOUS,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
NEWMAN_ERCC6_TARGETS_UP,NEWMAN_ERCC6_TARGETS_UP,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,CXCL2,1
PID_IL27_PATHWAY,PID_IL27_PATHWAY,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
REACTOME_REGULATION_OF_IFNA_SIGNALING,REACTOME_REGULATION_OF_IFNA_SIGNALING,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,CXCL3,1
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,CXCL2,1
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,1/22,26/21728,0.026009751597038222,0.06993818768031464,0.03454588217814585,STAT1,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,2/22,250/21728,0.026180070254663235,0.06993818768031464,0.03454588217814585,CXCL2/CXCL3,2
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,2/22,250/21728,0.026180070254663235,0.06993818768031464,0.03454588217814585,STAP1/MX1,2
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,2/22,251/21728,0.026374335560395135,0.07020641636717281,0.034678373409622376,IFI35/RSAD2,2
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,2/22,254/21728,0.026960698928690133,0.07085558904565127,0.034999031459363346,IFIT3/STAT1,2
BIOCARTA_EGF_PATHWAY,BIOCARTA_EGF_PATHWAY,1/22,27/21728,0.026997116147073008,0.07085558904565127,0.034999031459363346,STAT1,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1/22,27/21728,0.026997116147073008,0.07085558904565127,0.034999031459363346,CXCL2,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/22,27/21728,0.026997116147073008,0.07085558904565127,0.034999031459363346,STAT1,1
BIOCARTA_PDGF_PATHWAY,BIOCARTA_PDGF_PATHWAY,1/22,28/21728,0.027983525227058714,0.07318768136307664,0.03615096560433423,STAT1,1
BIOCARTA_BIOPEPTIDES_PATHWAY,BIOCARTA_BIOPEPTIDES_PATHWAY,1/22,29/21728,0.02896897971761203,0.07394456571926472,0.036524827705406576,STAT1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,1/22,29/21728,0.02896897971761203,0.07394456571926472,0.036524827705406576,STAT1,1
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,1/22,29/21728,0.02896897971761203,0.07394456571926472,0.036524827705406576,STAT1,1
WP_PDGFRBETA_PATHWAY,WP_PDGFRBETA_PATHWAY,1/22,29/21728,0.02896897971761203,0.07394456571926472,0.036524827705406576,STAT1,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,2/22,265/21728,0.029155987556718926,0.07394456571926472,0.036524827705406576,MX1/AIM2,2
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,2/22,265/21728,0.029155987556718926,0.07394456571926472,0.036524827705406576,CXCL2/CXCL3,2
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,2/22,265/21728,0.029155987556718926,0.07394456571926472,0.036524827705406576,OAS2/RSAD2,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,2/22,266/21728,0.029359050133173654,0.07394456571926472,0.036524827705406576,CXCL2/RNASE4,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,2/22,267/21728,0.029562689039554047,0.07394456571926472,0.036524827705406576,MX1/SLAMF7,2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,CXCL2,1
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,MX1,1
KIM_LRRC3B_TARGETS,KIM_LRRC3B_TARGETS,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,OAS2,1
MARSON_FOXP3_TARGETS_STIMULATED_UP,MARSON_FOXP3_TARGETS_STIMULATED_UP,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,CRTAM,1
REACTOME_SIGNALING_BY_CSF3_G_CSF,REACTOME_SIGNALING_BY_CSF3_G_CSF,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,STAT1,1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,IKBKE,1
SUMI_HNF4A_TARGETS,SUMI_HNF4A_TARGETS,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,SLC47A1,1
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,1/22,30/21728,0.029953480498579155,0.07394456571926472,0.036524827705406576,IKBKE,1
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,1/22,31/21728,0.030937028449037007,0.07587179436026126,0.0374767799330871,STAT1,1
WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1/22,31/21728,0.030937028449037007,0.07587179436026126,0.0374767799330871,CXCL2,1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,CXCL2,1
PID_IL12_STAT4_PATHWAY,PID_IL12_STAT4_PATHWAY,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,CD80,1
TAVOR_CEBPA_TARGETS_DN,TAVOR_CEBPA_TARGETS_DN,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,OAS2,1
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,OAS3,1
WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,IKBKE,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,1/22,32/21728,0.03191962444729146,0.07677131539091323,0.037921097244878334,IKBKE,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/22,279/21728,0.03205085299718678,0.07683986551889652,0.03795495749666856,CXCL2/CXCL3,2
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,2/22,280/21728,0.032261870227884536,0.07709865472989659,0.03808278611060189,STAP1/CXCL2,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,2/22,282/21728,0.032685580027939726,0.0773904071994253,0.03822689688572795,OAS2/SLC47A1,2
LIANG_SILENCED_BY_METHYLATION_UP,LIANG_SILENCED_BY_METHYLATION_UP,1/22,33/21728,0.03290126937087867,0.0773904071994253,0.03822689688572795,STAT1,1
PID_EPO_PATHWAY,PID_EPO_PATHWAY,1/22,33/21728,0.03290126937087867,0.0773904071994253,0.03822689688572795,STAT1,1
REACTOME_CD28_CO_STIMULATION,REACTOME_CD28_CO_STIMULATION,1/22,33/21728,0.03290126937087867,0.0773904071994253,0.03822689688572795,CD80,1
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,1/22,33/21728,0.03290126937087867,0.0773904071994253,0.03822689688572795,CD80,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,2/22,287/21728,0.03375456982551045,0.07842462200768528,0.0387377460240607,ADAMDEC1/SLC47A1,2
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1/22,34/21728,0.03388196409656885,0.07842462200768528,0.0387377460240607,CXCL3,1
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,1/22,34/21728,0.03388196409656885,0.07842462200768528,0.0387377460240607,CXCL2,1
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,1/22,34/21728,0.03388196409656885,0.07842462200768528,0.0387377460240607,STAT1,1
ZWANG_EGF_PERSISTENTLY_UP,ZWANG_EGF_PERSISTENTLY_UP,1/22,34/21728,0.03388196409656885,0.07842462200768528,0.0387377460240607,IFIT3,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,2/22,288/21728,0.033970023436484,0.07842462200768528,0.0387377460240607,IFIT3/IFI35,2
HONMA_DOCETAXEL_RESISTANCE,HONMA_DOCETAXEL_RESISTANCE,1/22,35/21728,0.03486170950036138,0.07926005685796447,0.03915040804551862,MX1,1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,1/22,35/21728,0.03486170950036138,0.07926005685796447,0.03915040804551862,STAT1,1
REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,1/22,35/21728,0.03486170950036138,0.07926005685796447,0.03915040804551862,IKBKE,1
ROZANOV_MMP14_TARGETS_DN,ROZANOV_MMP14_TARGETS_DN,1/22,35/21728,0.03486170950036138,0.07926005685796447,0.03915040804551862,ZNF185,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/22,35/21728,0.03486170950036138,0.07926005685796447,0.03915040804551862,CXCL2,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,2/22,293/21728,0.03505550248730926,0.07931567701243358,0.03917788155272191,AIM2/SLC47A1,2
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,2/22,295/21728,0.03549350318144733,0.07931567701243358,0.03917788155272191,IFIT3/RNASE4,2
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,STAT1,1
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,MX1,1
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,IFIT3,1
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,STAT1,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,STAT1,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,SLAMF7,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1/22,36/21728,0.03584050645749004,0.07931567701243358,0.03917788155272191,CXCL2,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,2/22,299/21728,0.03637598107104096,0.08005851793642872,0.03954480691765619,STAP1/ADAMDEC1,2
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,1/22,37/21728,0.03681835584242177,0.08005851793642872,0.03954480691765619,AIM2,1
KEGG_ALLOGRAFT_REJECTION,KEGG_ALLOGRAFT_REJECTION,1/22,37/21728,0.03681835584242177,0.08005851793642872,0.03954480691765619,CD80,1
PID_IL23_PATHWAY,PID_IL23_PATHWAY,1/22,37/21728,0.03681835584242177,0.08005851793642872,0.03954480691765619,STAT1,1
WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,WP_OVERVIEW_OF_INTERFERONSMEDIATED_SIGNALING_PATHWAY,1/22,37/21728,0.03681835584242177,0.08005851793642872,0.03954480691765619,STAT1,1
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,1/22,37/21728,0.03681835584242177,0.08005851793642872,0.03954480691765619,STAT1,1
HUANG_FOXA2_TARGETS_DN,HUANG_FOXA2_TARGETS_DN,1/22,38/21728,0.03779525852885679,0.08170766872712393,0.04035940293163594,CXCL2,1
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,1/22,38/21728,0.03779525852885679,0.08170766872712393,0.04035940293163594,STAT1,1
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,1/22,39/21728,0.03877121538973127,0.08333583078022698,0.04116363158437893,CXCL2,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/22,39/21728,0.03877121538973127,0.08333583078022698,0.04116363158437893,CXCL2,1
BROWNE_HCMV_INFECTION_2HR_UP,BROWNE_HCMV_INFECTION_2HR_UP,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,CXCL3,1
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,MX1,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,STAT1,1
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,STAT1,1
WP_IL5_SIGNALING_PATHWAY,WP_IL5_SIGNALING_PATHWAY,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,STAT1,1
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,CD80,1
WP_PDGF_PATHWAY,WP_PDGF_PATHWAY,1/22,40/21728,0.039746227297215886,0.08354274031827195,0.04126583429737329,STAT1,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,2/22,314/21728,0.03976098336003318,0.08354274031827195,0.04126583429737329,CXCL2/CXCL3,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,2/22,315/21728,0.0399908370035166,0.08379032515022526,0.04138812852199418,LAG3/SLAMF7,2
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,1/22,41/21728,0.040720295122716244,0.08460772431053265,0.041791881836471936,MX1,1
KEGG_GRAFT_VERSUS_HOST_DISEASE,KEGG_GRAFT_VERSUS_HOST_DISEASE,1/22,41/21728,0.040720295122716244,0.08460772431053265,0.041791881836471936,CD80,1
WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1/22,41/21728,0.040720295122716244,0.08460772431053265,0.041791881836471936,AIM2,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/22,319/21728,0.04091540631049349,0.08477762858794774,0.04187580584628435,ADAMDEC1/SLAMF7,2
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,1/22,42/21728,0.04169341973687701,0.08591371339720112,0.04243697354688657,STAT1,1
WP_IL2_SIGNALING_PATHWAY,WP_IL2_SIGNALING_PATHWAY,1/22,42/21728,0.04169341973687701,0.08591371339720112,0.04243697354688657,STAT1,1
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,IKBKE,1
KEGG_TYPE_I_DIABETES_MELLITUS,KEGG_TYPE_I_DIABETES_MELLITUS,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,CD80,1
KIM_LIVER_CANCER_POOR_SURVIVAL_DN,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,RNASE4,1
MUELLER_METHYLATED_IN_GLIOBLASTOMA,MUELLER_METHYLATED_IN_GLIOBLASTOMA,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,CXCL2,1
REACTOME_SIGNALING_BY_SCF_KIT,REACTOME_SIGNALING_BY_SCF_KIT,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,STAT1,1
WP_IL6_SIGNALING_PATHWAY,WP_IL6_SIGNALING_PATHWAY,1/22,43/21728,0.042665602009577586,0.08648745339610849,0.04272037171690696,STAT1,1
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,CXCL2,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,CXCL3,1
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,STAT1,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SHIPP_DLBCL_CURED_VS_FATAL_DN,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,STAT1,1
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,CXCL3,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/22,44/21728,0.04363684280993663,0.08701063031969988,0.042978794317780275,STAT1,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2/22,331/21728,0.043737963904020266,0.08701063031969988,0.042978794317780275,CXCL2/CXCL3,2
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/22,45/21728,0.0446071430063113,0.08757517839559278,0.04325765214868149,STAT1,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1/22,45/21728,0.0446071430063113,0.08757517839559278,0.04325765214868149,CXCL2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/22,45/21728,0.0446071430063113,0.08757517839559278,0.04325765214868149,CD80,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/22,45/21728,0.0446071430063113,0.08757517839559278,0.04325765214868149,STAT1,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,ZHAN_MULTIPLE_MYELOMA_MS_DN,1/22,45/21728,0.0446071430063113,0.08757517839559278,0.04325765214868149,OAS3,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/22,46/21728,0.04557650346629649,0.08831923469634657,0.04362517784747769,CXCL2,1
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,1/22,46/21728,0.04557650346629649,0.08831923469634657,0.04362517784747769,STAT1,1
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/22,46/21728,0.04557650346629649,0.08831923469634657,0.04362517784747769,STAT1,1
PID_TNF_PATHWAY,PID_TNF_PATHWAY,1/22,46/21728,0.04557650346629649,0.08831923469634657,0.04362517784747769,STAT1,1
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,1/22,46/21728,0.04557650346629649,0.08831923469634657,0.04362517784747769,STAT1,1
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,1/22,47/21728,0.04654492505672836,0.08920950509116858,0.044064925819026414,AIM2,1
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,1/22,47/21728,0.04654492505672836,0.08920950509116858,0.044064925819026414,LAMP3,1
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,1/22,47/21728,0.04654492505672836,0.08920950509116858,0.044064925819026414,STAT1,1
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,1/22,47/21728,0.04654492505672836,0.08920950509116858,0.044064925819026414,STAT1,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,2/22,343/21728,0.0466322412976563,0.08920950509116858,0.044064925819026414,CXCL2/CXCL3,2
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/22,48/21728,0.04751240864368245,0.09043074215133452,0.044668154369713504,STAT1,1
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,1/22,48/21728,0.04751240864368245,0.09043074215133452,0.044668154369713504,CD80,1
CROMER_TUMORIGENESIS_DN,CROMER_TUMORIGENESIS_DN,1/22,49/21728,0.048478955092475684,0.09134070128254863,0.04511762756849785,ZNF185,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_4,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1/22,49/21728,0.048478955092475684,0.09134070128254863,0.04511762756849785,IFIT3,1
REACTOME_SIGNALING_BY_NOTCH3,REACTOME_SIGNALING_BY_NOTCH3,1/22,49/21728,0.048478955092475684,0.09134070128254863,0.04511762756849785,STAT1,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/22,49/21728,0.048478955092475684,0.09134070128254863,0.04511762756849785,CXCL2,1
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,1/22,51/21728,0.050409240033056024,0.09450153269354863,0.046678916374100154,ZNF185,1
VILIMAS_NOTCH1_TARGETS_UP,VILIMAS_NOTCH1_TARGETS_UP,1/22,51/21728,0.050409240033056024,0.09450153269354863,0.046678916374100154,CD80,1
BROWNE_HCMV_INFECTION_1HR_UP,BROWNE_HCMV_INFECTION_1HR_UP,1/22,52/21728,0.05137298025168735,0.09582790331237441,0.04733407551737042,CXCL2,1
KEGG_AUTOIMMUNE_THYROID_DISEASE,KEGG_AUTOIMMUNE_THYROID_DISEASE,1/22,52/21728,0.05137298025168735,0.09582790331237441,0.04733407551737042,CD80,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1/22,53/21728,0.052335786785847715,0.09665967534768911,0.047744928295861085,CXCL2,1
PID_CD8_TCR_PATHWAY,PID_CD8_TCR_PATHWAY,1/22,53/21728,0.052335786785847715,0.09665967534768911,0.047744928295861085,CD80,1
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,1/22,53/21728,0.052335786785847715,0.09665967534768911,0.047744928295861085,RNASE4,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,1/22,53/21728,0.052335786785847715,0.09665967534768911,0.047744928295861085,STAP1,1
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,1/22,54/21728,0.053297660497068744,0.09795245712974797,0.04838349627433371,RNASE4,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/22,54/21728,0.053297660497068744,0.09795245712974797,0.04838349627433371,ZNF185,1
PID_FGF_PATHWAY,PID_FGF_PATHWAY,1/22,55/21728,0.054258602246125665,0.09850833611675243,0.0486580720193922,STAT1,1
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,1/22,55/21728,0.054258602246125665,0.09850833611675243,0.0486580720193922,STAT1,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/22,55/21728,0.054258602246125665,0.09850833611675243,0.0486580720193922,STAT1,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/22,55/21728,0.054258602246125665,0.09850833611675243,0.0486580720193922,STAT1,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/22,55/21728,0.054258602246125665,0.09850833611675243,0.0486580720193922,STAT1,1
GRADE_COLON_VS_RECTAL_CANCER_DN,GRADE_COLON_VS_RECTAL_CANCER_DN,1/22,56/21728,0.05521861289304075,0.09928731356729444,0.04904284697737172,RNASE4,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/22,56/21728,0.05521861289304075,0.09928731356729444,0.04904284697737172,AIM2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1/22,56/21728,0.05521861289304075,0.09928731356729444,0.04904284697737172,ADAMDEC1,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/22,56/21728,0.05521861289304075,0.09928731356729444,0.04904284697737172,STAT1,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/22,57/21728,0.056177693297080555,0.1002885789647166,0.04953742079456168,STAT1,1
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,1/22,57/21728,0.056177693297080555,0.1002885789647166,0.04953742079456168,STAT1,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/22,57/21728,0.056177693297080555,0.1002885789647166,0.04953742079456168,IKBKE,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/22,383/21728,0.0567727536160994,0.10079625365315109,0.049788186085358906,OAS2/RSAD2,2
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/22,384/21728,0.057035583024657346,0.10079625365315109,0.049788186085358906,STAP1/SLAMF7,2
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,1/22,58/21728,0.05713584431675944,0.10079625365315109,0.049788186085358906,STAT1,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/22,58/21728,0.05713584431675944,0.10079625365315109,0.049788186085358906,SLC47A1,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/22,58/21728,0.05713584431675944,0.10079625365315109,0.049788186085358906,STAT1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1/22,59/21728,0.05809306680983939,0.1012904754633097,0.05003230634340235,STAT1,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/22,59/21728,0.05809306680983939,0.1012904754633097,0.05003230634340235,CXCL2,1
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1/22,59/21728,0.05809306680983939,0.1012904754633097,0.05003230634340235,ADAMDEC1,1
RAMASWAMY_METASTASIS_DN,RAMASWAMY_METASTASIS_DN,1/22,59/21728,0.05809306680983939,0.1012904754633097,0.05003230634340235,RNASE4,1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,1/22,59/21728,0.05809306680983939,0.1012904754633097,0.05003230634340235,STAT1,1
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,1/22,60/21728,0.05904936163332808,0.1027184244226265,0.05073763998359402,STAT1,1
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,1/22,61/21728,0.060004729643484245,0.10328178909778532,0.05101591327515149,CXCL2,1
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/22,61/21728,0.060004729643484245,0.10328178909778532,0.05101591327515149,CXCL3,1
GRABARCZYK_BCL11B_TARGETS_DN,GRABARCZYK_BCL11B_TARGETS_DN,1/22,61/21728,0.060004729643484245,0.10328178909778532,0.05101591327515149,LAMP3,1
WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,1/22,61/21728,0.060004729643484245,0.10328178909778532,0.05101591327515149,IKBKE,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,2/22,398/21728,0.06076084015238869,0.10328178909778532,0.05101591327515149,MX1/IKBKE,2
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,OAS2,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,STAT1,1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,CXCL2,1
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,STAT1,1
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,STAT1,1
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1/22,62/21728,0.06095917169581455,0.10328178909778532,0.05101591327515149,STAT1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,2/22,399/21728,0.06103014810323678,0.10328178909778532,0.05101591327515149,ZNF185/STAT1,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,1/22,63/21728,0.06191268864507604,0.10377191105641895,0.051258008416553695,IFIT3,1
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,1/22,63/21728,0.06191268864507604,0.10377191105641895,0.051258008416553695,STAT1,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/22,63/21728,0.06191268864507604,0.10377191105641895,0.051258008416553695,CXCL2,1
ZHANG_GATA6_TARGETS_DN,ZHANG_GATA6_TARGETS_DN,1/22,63/21728,0.06191268864507604,0.10377191105641895,0.051258008416553695,LAMP3,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,OAS2,1
GOLDRATH_IMMUNE_MEMORY,GOLDRATH_IMMUNE_MEMORY,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,RNASE4,1
KIM_GERMINAL_CENTER_T_HELPER_UP,KIM_GERMINAL_CENTER_T_HELPER_UP,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,STAT1,1
LIAN_LIPA_TARGETS_3M,LIAN_LIPA_TARGETS_3M,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,CXCL3,1
PID_TCR_PATHWAY,PID_TCR_PATHWAY,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,CD80,1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1/22,64/21728,0.06286528134527469,0.10377191105641895,0.051258008416553695,AIM2,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/22,407/21728,0.06319976997824088,0.10377191105641895,0.051258008416553695,IFIT3/RSAD2,2
BROWNE_HCMV_INFECTION_6HR_UP,BROWNE_HCMV_INFECTION_6HR_UP,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,MX1,1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,AIM2,1
LEE_LIVER_CANCER_ACOX1_DN,LEE_LIVER_CANCER_ACOX1_DN,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,RNASE4,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,SLAMF7,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,STAT1,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,STAT1,1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,1/22,65/21728,0.06381695064966941,0.10377191105641895,0.051258008416553695,STAT1,1
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1/22,66/21728,0.06476769741076938,0.10463550251243087,0.05168457835894067,RNASE4,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/22,66/21728,0.06476769741076938,0.10463550251243087,0.05168457835894067,STAT1,1
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,1/22,66/21728,0.06476769741076938,0.10463550251243087,0.05168457835894067,STAT1,1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1/22,67/21728,0.06571752248033647,0.10594117848123205,0.05232951540516811,SLAMF7,1
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/22,68/21728,0.0666664267093855,0.10678048646385514,0.05274409055560534,CXCL2,1
JI_RESPONSE_TO_FSH_UP,JI_RESPONSE_TO_FSH_UP,1/22,68/21728,0.0666664267093855,0.10678048646385514,0.05274409055560534,IFI35,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/22,68/21728,0.0666664267093855,0.10678048646385514,0.05274409055560534,STAT1,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,2/22,421/21728,0.06706023259089644,0.10718173926921055,0.052942288887549815,MX1/SAMD9,2
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/22,69/21728,0.06761441094818466,0.10783705626704078,0.05326598191631201,STAP1,1
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,1/22,70/21728,0.06856147604625695,0.10842279932896448,0.053555308984613754,STAT1,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/22,70/21728,0.06856147604625695,0.10842279932896448,0.053555308984613754,CD80,1
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,1/22,70/21728,0.06856147604625695,0.10842279932896448,0.053555308984613754,STAT1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1/22,70/21728,0.06856147604625695,0.10842279932896448,0.053555308984613754,ADAMDEC1,1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/22,71/21728,0.06950762285237844,0.10911646363571356,0.05389794361966713,IKBKE,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1/22,71/21728,0.06950762285237844,0.10911646363571356,0.05389794361966713,CXCL3,1
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1/22,71/21728,0.06950762285237844,0.10911646363571356,0.05389794361966713,ZNF185,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/22,430/21728,0.06958362721154461,0.10911646363571356,0.05389794361966713,STAT1/CXCL2,2
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2/22,432/21728,0.07014871765618444,0.10977247030716727,0.054221977311871256,CD80/STAT1,2
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,1/22,72/21728,0.07045285221458253,0.1100182326858199,0.054343371337915544,STAT1,1
REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1/22,73/21728,0.07139716498015647,0.11126058209407716,0.054957028307094126,STAT1,1
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/22,74/21728,0.07234056199564676,0.11179905035690862,0.05522300404626362,CXCL2,1
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1/22,74/21728,0.07234056199564676,0.11179905035690862,0.05522300404626362,CD80,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,1/22,74/21728,0.07234056199564676,0.11179905035690862,0.05522300404626362,IFIT3,1
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1/22,74/21728,0.07234056199564676,0.11179905035690862,0.05522300404626362,CD80,1
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,1/22,75/21728,0.07328304410685438,0.11255794043516852,0.055597856871297716,SAMD9,1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1/22,75/21728,0.07328304410685438,0.11255794043516852,0.055597856871297716,ZNF185,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/22,75/21728,0.07328304410685438,0.11255794043516852,0.055597856871297716,SAMD9,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,2/22,445/21728,0.07385946300304592,0.11284554856669174,0.05573992055573994,STAT1/CXCL2,2
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/22,76/21728,0.07422461215884002,0.11284554856669174,0.05573992055573994,CXCL3,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/22,76/21728,0.07422461215884002,0.11284554856669174,0.05573992055573994,STAT1,1
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,1/22,76/21728,0.07422461215884002,0.11284554856669174,0.05573992055573994,STAT1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1/22,76/21728,0.07422461215884002,0.11284554856669174,0.05573992055573994,IFIT3,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/22,77/21728,0.07516526699592241,0.11358307012717164,0.05610421842757845,STAT1,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/22,77/21728,0.07516526699592241,0.11358307012717164,0.05610421842757845,MX1,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/22,77/21728,0.07516526699592241,0.11358307012717164,0.05610421842757845,SAMD9,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/22,451/21728,0.07559373718352576,0.114000232688059,0.05631027536378935,SLAMF7/CXCL3,2
DARWICHE_PAPILLOMA_PROGRESSION_RISK,DARWICHE_PAPILLOMA_PROGRESSION_RISK,1/22,78/21728,0.07610500946167886,0.11418588553254862,0.05640197835902697,LAG3,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/22,78/21728,0.07610500946167886,0.11418588553254862,0.05640197835902697,CD80,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,2/22,453/21728,0.07617480866409326,0.11418588553254862,0.05640197835902697,ADAMDEC1/RNASE4,2
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/22,79/21728,0.07704384039894663,0.11525758523682415,0.05693134311585319,IFIT3,1
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,1/22,80/21728,0.07798176064982298,0.11596492438582025,0.05728073242249214,IFIT3,1
LIAN_LIPA_TARGETS_6M,LIAN_LIPA_TARGETS_6M,1/22,80/21728,0.07798176064982298,0.11596492438582025,0.05728073242249214,CXCL3,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/22,80/21728,0.07798176064982298,0.11596492438582025,0.05728073242249214,RNASE4,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,2/22,461/21728,0.0785137890403578,0.11620903618270194,0.057401311145691504,LAMP3/STAT1,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/22,81/21728,0.07891877105566669,0.11620903618270194,0.057401311145691504,STAT1,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/22,81/21728,0.07891877105566669,0.11620903618270194,0.057401311145691504,CXCL3,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/22,81/21728,0.07891877105566669,0.11620903618270194,0.057401311145691504,SLAMF7,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,2/22,463/21728,0.07910216938041985,0.11620903618270194,0.057401311145691504,CXCL2/CXCL3,2
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,STAT1,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,IKBKE,1
RIZ_ERYTHROID_DIFFERENTIATION,RIZ_ERYTHROID_DIFFERENTIATION,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,STAT1,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,RNASE4,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,RNASE4,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/22,82/21728,0.07985487245709733,0.11620903618270194,0.057401311145691504,MX1,1
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/22,83/21728,0.0807900656939976,0.11734168764875769,0.057960782950624755,SLC47A1,1
HILLION_HMGA1_TARGETS,HILLION_HMGA1_TARGETS,1/22,84/21728,0.08172435160551239,0.11778384393241478,0.0581791855055975,CXCL2,1
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,1/22,84/21728,0.08172435160551239,0.11778384393241478,0.0581791855055975,CXCL3,1
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,1/22,84/21728,0.08172435160551239,0.11778384393241478,0.0581791855055975,STAT1,1
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1/22,84/21728,0.08172435160551239,0.11778384393241478,0.0581791855055975,CXCL2,1
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,1/22,85/21728,0.08265773103004914,0.1184444115143233,0.058505472053936775,CXCL2,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1/22,85/21728,0.08265773103004914,0.1184444115143233,0.058505472053936775,CXCL3,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/22,85/21728,0.08265773103004914,0.1184444115143233,0.058505472053936775,STAT1,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/22,86/21728,0.0835902048052809,0.1188697209018063,0.05871555310517029,SLC47A1,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/22,86/21728,0.0835902048052809,0.1188697209018063,0.05871555310517029,CRTAM,1
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,1/22,86/21728,0.0835902048052809,0.1188697209018063,0.05871555310517029,SLC47A1,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/22,86/21728,0.0835902048052809,0.1188697209018063,0.05871555310517029,STAT1,1
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,1/22,87/21728,0.08452177376814429,0.11951282944909628,0.059033215784735145,MX1,1
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,1/22,87/21728,0.08452177376814429,0.11951282944909628,0.059033215784735145,CXCL2,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/22,87/21728,0.08452177376814429,0.11951282944909628,0.059033215784735145,CD80,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/22,482/21728,0.08476247688328223,0.11962704284659453,0.05908963135259595,MX1/CXCL2,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,2/22,483/21728,0.08506386259527045,0.11982630738467476,0.05918805782721762,CXCL2/CXCL3,2
JIANG_VHL_TARGETS,JIANG_VHL_TARGETS,1/22,88/21728,0.08545243875484043,0.11987733960932745,0.059213265132105175,IKBKE,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/22,88/21728,0.08545243875484043,0.11987733960932745,0.059213265132105175,CXCL3,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,2/22,485/21728,0.08566765600384259,0.11987733960932745,0.059213265132105175,SLAMF7/CXCL3,2
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/22,89/21728,0.0863822006008389,0.11987733960932745,0.059213265132105175,STAT1,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,1/22,89/21728,0.0863822006008389,0.11987733960932745,0.059213265132105175,LAG3,1
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,1/22,89/21728,0.0863822006008389,0.11987733960932745,0.059213265132105175,STAT1,1
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1/22,89/21728,0.0863822006008389,0.11987733960932745,0.059213265132105175,STAT1,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1/22,89/21728,0.0863822006008389,0.11987733960932745,0.059213265132105175,CD80,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/22,90/21728,0.08731106014087153,0.12094198700994796,0.059739146412175266,SLC47A1,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,2/22,495/21728,0.08870682386879115,0.12260335400268667,0.06055977660419789,IFIT3/CXCL3,2
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,2/22,496/21728,0.08901257061404608,0.12260335400268667,0.06055977660419789,IFIT3/AIM2,2
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1/22,92/21728,0.08916607563831758,0.12260335400268667,0.06055977660419789,MX1,1
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,1/22,92/21728,0.08916607563831758,0.12260335400268667,0.06055977660419789,RNASE4,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/22,93/21728,0.09009223326153659,0.12364952381583372,0.06107653090255788,LAMP3,1
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,1/22,94/21728,0.09101749191040376,0.1246906299431905,0.061590783999521344,SAMD9,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/22,96/21728,0.09286531560865707,0.12675776656072169,0.0626118436009194,IFI35,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/22,96/21728,0.09286531560865707,0.12675776656072169,0.0626118436009194,IFI35,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/22,97/21728,0.09378788231800461,0.12778385423290975,0.0631186783503396,IKBKE,1
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,1/22,99/21728,0.095630329601580355,0.1300572482581493,0.06424161854575064,STAT1,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/22,100/21728,0.09655021183140011,0.13059594656399148,0.06450770791438364,STAT1,1
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,1/22,100/21728,0.09655021183140011,0.13059594656399148,0.06450770791438364,RNASE4,1
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,1/22,100/21728,0.09655021183140011,0.13059594656399148,0.06450770791438364,STAT1,1
GAVIN_FOXP3_TARGETS_CLUSTER_T7,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1/22,101/21728,0.09746920088908961,0.13089221232502518,0.06465404802432288,STAT1,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/22,101/21728,0.09746920088908961,0.13089221232502518,0.06465404802432288,STAT1,1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1/22,101/21728,0.09746920088908961,0.13089221232502518,0.06465404802432288,SLAMF7,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/22,101/21728,0.09746920088908961,0.13089221232502518,0.06465404802432288,IKBKE,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/22,103/21728,0.09930450279126823,0.1328797282430566,0.06563577907868401,STAT1,1
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,1/22,103/21728,0.09930450279126823,0.1328797282430566,0.06563577907868401,STAT1,1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1/22,105/21728,0.1011362419072418,0.1341310442315902,0.06625386507921215,RNASE4,1
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/22,105/21728,0.1011362419072418,0.1341310442315902,0.06625386507921215,STAT1,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/22,105/21728,0.1011362419072418,0.1341310442315902,0.06625386507921215,CD80,1
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,1/22,105/21728,0.1011362419072418,0.1341310442315902,0.06625386507921215,LAMP3,1
XU_GH1_EXOGENOUS_TARGETS_DN,XU_GH1_EXOGENOUS_TARGETS_DN,1/22,105/21728,0.1011362419072418,0.1341310442315902,0.06625386507921215,OAS2,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,1/22,106/21728,0.10205077747945845,0.1348656917926412,0.06661674334255145,OAS2,1
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,1/22,106/21728,0.10205077747945845,0.1348656917926412,0.06661674334255145,LAMP3,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/22,107/21728,0.10296442482454482,0.13511822766449041,0.06674148312726728,SLC47A1,1
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1/22,107/21728,0.10296442482454482,0.13511822766449041,0.06674148312726728,IFI35,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/22,107/21728,0.10296442482454482,0.13511822766449041,0.06674148312726728,SAMD9,1
SERVITJA_ISLET_HNF1A_TARGETS_DN,SERVITJA_ISLET_HNF1A_TARGETS_DN,1/22,107/21728,0.10296442482454482,0.13511822766449041,0.06674148312726728,RNASE4,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/22,109/21728,0.1047890581191383,0.13703184523271933,0.06768671218221853,IKBKE,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/22,109/21728,0.1047890581191383,0.13703184523271933,0.06768671218221853,RNASE4,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/22,110/21728,0.10570004570974734,0.1379819095827068,0.06815599530471446,STAT1,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/22,111/21728,0.10661014835543103,0.13892751040045717,0.06862307367092663,STAT1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/22,112/21728,0.10751936687493768,0.13986867203904937,0.06908795931002862,ADAMDEC1,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/22,113/21728,0.1084277020862976,0.14031820269991455,0.0693100044295947,OAS2,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/22,113/21728,0.1084277020862976,0.14031820269991455,0.0693100044295947,ZNF185,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/22,113/21728,0.1084277020862976,0.14031820269991455,0.0693100044295947,CD80,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/22,114/21728,0.10933515480681966,0.14124817926684127,0.06976936521624161,AIM2,1
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,1/22,116/21728,0.11114741604100475,0.14334183999770958,0.07080352637094858,AIM2,1
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/22,117/21728,0.11205222618569755,0.14426000892754176,0.07125705478970892,OAS2,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/22,119/21728,0.11385920960248441,0.1458333712031821,0.07203421515946654,ZNF185,1
WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,1/22,119/21728,0.11385920960248441,0.1458333712031821,0.07203421515946654,STAT1,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/22,119/21728,0.11385920960248441,0.1458333712031821,0.07203421515946654,CXCL2,1
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,1/22,120/21728,0.11476138450131068,0.14648722799826003,0.07235718692286698,RNASE4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/22,120/21728,0.11476138450131068,0.14648722799826003,0.07235718692286698,STAT1,1
KEGG_LYSOSOME,KEGG_LYSOSOME,1/22,121/21728,0.1156626826103897,0.1473861781815528,0.07280122226530401,LAMP3,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/22,122/21728,0.1165631047412996,0.14828095637158523,0.07324319685677795,ZNF185,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1/22,126/21728,0.12015604968987281,0.15233343248817774,0.07524491247305148,CXCL2,1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1/22,126/21728,0.12015604968987281,0.15233343248817774,0.07524491247305148,LAG3,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/22,127/21728,0.12105210407867129,0.15320976962918126,0.07567777813093528,STAP1,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/22,128/21728,0.12194728734381044,0.15382221067988233,0.0759802926381068,AIM2,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/22,128/21728,0.12194728734381044,0.15382221067988233,0.0759802926381068,RSAD2,1
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,1/22,129/21728,0.12284160029188596,0.15468942258978233,0.0764086508992592,STAT1,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/22,131/21728,0.12462761845968462,0.15588872676897006,0.07700104573023993,CXCL2,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/22,131/21728,0.12462761845968462,0.15588872676897006,0.07700104573023993,LAMP3,1
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,1/22,131/21728,0.12462761845968462,0.15588872676897006,0.07700104573023993,RNASE4,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/22,131/21728,0.12462761845968462,0.15588872676897006,0.07700104573023993,STAT1,1
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1/22,132/21728,0.12551932528905352,0.15674199551955262,0.07742251678491835,IFI35,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,1/22,133/21728,0.12641016502065405,0.15732912385266096,0.07771252810622573,RNASE4,1
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,1/22,133/21728,0.12641016502065405,0.15732912385266096,0.07771252810622573,CD80,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/22,135/21728,0.1281892464020581,0.15901418956673208,0.07854486425263577,CXCL2,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/22,135/21728,0.1281892464020581,0.15901418956673208,0.07854486425263577,RSAD2,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1/22,137/21728,0.12996486901985504,0.1609498709053834,0.07950099167997407,IFI35,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/22,138/21728,0.13085138529430096,0.16177989454568117,0.07991098084088671,OAS3,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/22,139/21728,0.13173703927871672,0.16233822962187827,0.08018676976819486,CXCL3,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/22,139/21728,0.13173703927871672,0.16233822962187827,0.08018676976819486,CD80,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,1/22,140/21728,0.13262183177192477,0.1628918393520521,0.08046022461662015,ADAMDEC1,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/22,140/21728,0.13262183177192477,0.1628918393520521,0.08046022461662015,RNASE4,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/22,141/21728,0.1335057635720459,0.1637087068063776,0.08086371529557915,RNASE4,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/22,143/21728,0.13527104828199799,0.16533128123355312,0.08166518394733624,CXCL2,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/22,143/21728,0.13527104828199799,0.16533128123355312,0.08166518394733624,RSAD2,1
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,1/22,144/21728,0.13615240278455998,0.1658585906716248,0.08192564779867761,STAT1,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/22,144/21728,0.13615240278455998,0.1658585906716248,0.08192564779867761,STAT1,1
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,1/22,145/21728,0.1370328997794975,0.1658585906716248,0.08192564779867761,IFIT3,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/22,145/21728,0.1370328997794975,0.1658585906716248,0.08192564779867761,CXCL3,1
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,1/22,145/21728,0.1370328997794975,0.1658585906716248,0.08192564779867761,CXCL2,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/22,145/21728,0.1370328997794975,0.1658585906716248,0.08192564779867761,STAT1,1
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/22,146/21728,0.13791254006142573,0.16665360252980038,0.08231834293267652,CXCL2,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/22,148/21728,0.1396692536612102,0.1685041963525568,0.0832324414857127,IFIT3,1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,1/22,150/21728,0.14142254992684433,0.17034471392154518,0.08414156288553669,STAP1,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/22,151/21728,0.14229791853846818,0.1711235419079971,0.08452626401591189,CXCL2,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/22,152/21728,0.14317243519009482,0.17189884674508976,0.08490922489097454,RNASE4,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/22,153/21728,0.1440461006714543,0.17267064631770482,0.08529045434494004,SAMD9,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1/22,154/21728,0.14491891577158134,0.1731618993564582,0.08553310818198259,IKBKE,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/22,154/21728,0.14491891577158134,0.1731618993564582,0.08553310818198259,CXCL2,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/22,155/21728,0.14579088127881323,0.17364901145947817,0.08577371660888944,STAT1,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/22,155/21728,0.14579088127881323,0.17364901145947817,0.08577371660888944,IKBKE,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/22,159/21728,0.14927026312128833,0.17722882034083123,0.08754195882301119,ZNF185,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,1/22,159/21728,0.14927026312128833,0.17722882034083123,0.08754195882301119,STAT1,1
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1/22,160/21728,0.1501379924648525,0.17797657426895352,0.087911310960319,MX1,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/22,163/21728,0.15273611436429213,0.18076995814001665,0.08929109950344194,STAT1,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/22,165/21728,0.15446398168082587,0.18252615844748457,0.09015857249516901,CD80,1
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,1/22,166/21728,0.1553266534984309,0.18325605176155568,0.09051910240403328,IKBKE,1
DURAND_STROMA_NS_UP,DURAND_STROMA_NS_UP,1/22,167/21728,0.15618848512921835,0.1839826564986698,0.09087800792433591,AIM2,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/22,168/21728,0.15704947735254537,0.18441602678132485,0.09109207064487058,LAMP3,1
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,1/22,168/21728,0.15704947735254537,0.18441602678132485,0.09109207064487058,STAT1,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/22,169/21728,0.15790963094708343,0.18513542938623573,0.09144741868078912,SLC47A1,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/22,170/21728,0.15876894669081776,0.18585159956922018,0.09180117006585459,AIM2,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,1/22,172/21728,0.16048506773438542,0.18756692291456295,0.09264845193218632,RNASE4,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/22,173/21728,0.16134187458676286,0.1882741375833052,0.09299777975195626,ZNF185,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/22,175/21728,0.1630529848289327,0.1899745056885384,0.09383767449574584,SLC47A1,1
BAKKER_FOXO3_TARGETS_DN,BAKKER_FOXO3_TARGETS_DN,1/22,177/21728,0.1647607622813242,0.19166570791046733,0.09467304176269918,IFI35,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/22,179/21728,0.16646521312678964,0.19334779412863146,0.09550390619075377,RSAD2,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/22,181/21728,0.16816634353728332,0.19502081390060141,0.09633029225881101,CXCL2,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/22,182/21728,0.169015665505176,0.19570234953230906,0.096666935949677,CXCL2,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/22,183/21728,0.16986415967387947,0.19607776456182383,0.09685237174387865,ZNF185,1
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,1/22,183/21728,0.16986415967387947,0.19607776456182383,0.09685237174387865,STAT1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1/22,184/21728,0.17071182681183128,0.19675261395261912,0.09718571277423206,IFI35,1
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,1/22,187/21728,0.17324987371538958,0.1990643710278209,0.09832760235120341,STAP1,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/22,187/21728,0.17324987371538958,0.1990643710278209,0.09832760235120341,IKBKE,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/22,191/21728,0.17662240432301868,0.20262815710677604,0.10008793012169771,ADAMDEC1,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/22,193/21728,0.17830374112673653,0.2042437953488498,0.10088597265331589,ZNF185,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/22,194/21728,0.17914318007241659,0.20489158821738168,0.10120594914762308,RNASE4,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/22,200/21728,0.18416264926158332,0.20999033787753707,0.10372447029976854,CXCL2,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,1/22,200/21728,0.18416264926158332,0.20999033787753707,0.10372447029976854,CXCL3,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,1/22,201/21728,0.18499637379318146,0.2106199202394212,0.1040354517366125,STAT1,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/22,203/21728,0.18666138366938245,0.211870584195293,0.10465321566640562,STAP1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1/22,203/21728,0.18666138366938245,0.211870584195293,0.10465321566640562,MX1,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,1/22,205/21728,0.1883231463306384,0.21343289917472352,0.1054249192377258,RNASE4,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/22,207/21728,0.18998166780887993,0.21433829188694145,0.10587213685943773,CXCL2,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/22,207/21728,0.18998166780887993,0.21433829188694145,0.10587213685943773,MX1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,1/22,207/21728,0.18998166780887993,0.21433829188694145,0.10587213685943773,CXCL3,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1/22,210/21728,0.19246338597674328,0.21681116372078912,0.10709360887418656,ADAMDEC1,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/22,211/21728,0.19328901129082965,0.21741380518126405,0.10739128288576368,CD80,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/22,215/21728,0.1965834621580831,0.22078743197334258,0.10905768170932063,LAMP3,1
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,1/22,219/21728,0.19986506828401607,0.2241365383454933,0.11071196870147501,STAT1,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/22,221/21728,0.201501069483217,0.2256329340919855,0.11145111154839138,STAT1,1
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1/22,223/21728,0.20313387737309752,0.22712128591192368,0.11218628110763468,CXCL2,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/22,224/21728,0.20394908568269055,0.2273530791216878,0.11230077507980922,LAMP3,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/22,224/21728,0.20394908568269055,0.2273530791216878,0.11230077507980922,LAMP3,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1/22,225/21728,0.2047634978904187,0.2279212744375494,0.11258143446042758,IKBKE,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/22,227/21728,0.20638993696145158,0.2293903014073786,0.1133070585336193,ZNF185,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,1/22,232/21728,0.21044215460827664,0.233547079594942,0.1153602940301501,CXCL2,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1/22,235/21728,0.21286399694213054,0.23588484401883503,0.11651502990516621,IKBKE,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/22,236/21728,0.21366970075580338,0.23607819226785956,0.11661053403605223,OAS2,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/22,236/21728,0.21366970075580338,0.23607819226785956,0.11661053403605223,STAT1,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/22,237/21728,0.21447461731002682,0.236269534238439,0.11670504716815658,RSAD2,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,1/22,237/21728,0.21447461731002682,0.236269534238439,0.11670504716815658,CXCL2,1
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,1/22,238/21728,0.21527874733744223,0.2364588884117574,0.11679857843023762,LAG3,1
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,1/22,238/21728,0.21527874733744223,0.2364588884117574,0.11679857843023762,ADAMDEC1,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/22,243/21728,0.21928762516951716,0.24050900825043817,0.11879913016592149,CXCL3,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/22,245/21728,0.2208856961846717,0.2415533636639392,0.11931498824379773,CXCL3,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/22,245/21728,0.2208856961846717,0.2415533636639392,0.11931498824379773,STAT1,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/22,249/21728,0.22407247575768485,0.24468060126532593,0.12085968342827105,SLC47A1,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,1/22,257/21728,0.23040874745330175,0.25123286165462055,0.1240961644255162,RNASE4,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/22,259/21728,0.23198508086773817,0.2522163379201572,0.12458195132279085,ZNF185,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1/22,259/21728,0.23198508086773817,0.2522163379201572,0.12458195132279085,IKBKE,1
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,1/22,262/21728,0.23434380349528383,0.25441097970170146,0.12566599194384634,RNASE4,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/22,265/21728,0.2366956103399519,0.25622042913789295,0.12655976727751256,CD80,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/22,265/21728,0.2366956103399519,0.25622042913789295,0.12655976727751256,ADAMDEC1,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/22,268/21728,0.23904052071596305,0.2583848403114745,0.12762887552677674,STAT1,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/22,271/21728,0.24137855388628682,0.2601601704710988,0.1285057976855554,SLC47A1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/22,271/21728,0.24137855388628682,0.2601601704710988,0.1285057976855554,ZNF185,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/22,281/21728,0.24912257536860638,0.2681204120513922,0.13243774926827845,ZNF185,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/22,290/21728,0.25602762820614866,0.2751561291640793,0.13591303312213882,AIM2,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/22,293/21728,0.25831581228511247,0.27681981029980535,0.13673480638225677,ZNF185,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,1/22,293/21728,0.25831581228511247,0.27681981029980535,0.13673480638225677,CXCL3,1
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1/22,296/21728,0.26059727770725316,0.27806956308848124,0.13735212024212906,LAG3,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/22,296/21728,0.26059727770725316,0.27806956308848124,0.13735212024212906,MX1,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,1/22,296/21728,0.26059727770725316,0.27806956308848124,0.13735212024212906,AIM2,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,1/22,300/21728,0.2636288128302344,0.2809036353233837,0.13875200675275495,STAT1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,1/22,304/21728,0.26664848147767983,0.28371701869886845,0.14014167402660122,STAT1,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/22,307/21728,0.2689054722112397,0.28571206422444223,0.14112712432138927,CD80,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/22,313/21728,0.2733995780592595,0.29007501331677465,0.14328219768391207,MX1,1
SHEN_SMARCA2_TARGETS_DN,SHEN_SMARCA2_TARGETS_DN,1/22,322/21728,0.28009132542688286,0.2963342452889793,0.14637393765329543,IKBKE,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/22,322/21728,0.28009132542688286,0.2963342452889793,0.14637393765329543,STAP1,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1/22,324/21728,0.2815703707112911,0.29741829055109636,0.1469094004833026,LAMP3,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/22,325/21728,0.2823088052022439,0.29741829055109636,0.1469094004833026,CRTAM,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/22,325/21728,0.2823088052022439,0.29741829055109636,0.1469094004833026,STAT1,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/22,327/21728,0.28378350126999485,0.29855141905760363,0.1474691079217828,IFI35,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1/22,329/21728,0.2852553046296544,0.29967832565025493,0.1480257420535315,LAMP3,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,1/22,341/21728,0.2940256799007692,0.30845891804456577,0.15236290491646856,IKBKE,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,1/22,345/21728,0.29692624054874683,0.3110655853367824,0.15365046503407068,IFI35,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/22,357/21728,0.3055598264625736,0.3196625876839232,0.15789694381798064,RNASE4,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,1/22,359/21728,0.30698888240144007,0.3207090559165882,0.1584138455202962,STAT1,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,1/22,361/21728,0.30841513096247675,0.32130155704725993,0.15870651072838196,IKBKE,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,1/22,361/21728,0.30841513096247675,0.32130155704725993,0.15870651072838196,SAMD9,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/22,366/21728,0.3119685045366142,0.3245513788503302,0.1603117562291949,LAG3,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1/22,371/21728,0.3155044466271886,0.3277740639960237,0.16190359761132045,IKBKE,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/22,377/21728,0.3197246822466191,0.33150536029993605,0.16374666685234665,SLC47A1,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1/22,378/21728,0.3204256356909809,0.33150536029993605,0.16374666685234665,CD80,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/22,378/21728,0.3204256356909809,0.33150536029993605,0.16374666685234665,CD80,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/22,382/21728,0.3232225613004793,0.3339371213435891,0.16494783224261156,STAT1,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/22,384/21728,0.324616900232937,0.3349150915506715,0.16543089942905392,STAT1,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,1/22,387/21728,0.3267032682690495,0.3366033673075055,0.16626482117215655,IKBKE,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,1/22,388/21728,0.3273973560858382,0.3368545011722242,0.16638886843716674,IFIT3,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1/22,389/21728,0.32809076087337863,0.3371042433149549,0.16651222826280496,CRTAM,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,1/22,400/21728,0.335673316287587,0.34442200354336777,0.17012682696836767,RNASE4,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/22,416/21728,0.3465568307801663,0.3551020677035129,0.17540223158448212,IFI35,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/22,423/21728,0.351264658663217,0.3594336042135244,0.17754178874042648,IFIT3,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/22,433/21728,0.3579339979841243,0.3652587046277285,0.18041908995825034,CXCL2,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,1/22,433/21728,0.3579339979841243,0.3652587046277285,0.18041908995825034,IFI35,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,1/22,436/21728,0.3599220035224818,0.3667870008648725,0.18117399001346782,CXCL3,1
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,1/22,438/21728,0.36124407484478227,0.3676334258284315,0.18159208058792495,STAT1,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,1/22,445/21728,0.3658508277203004,0.3713112878355288,0.18340875602345988,STAP1,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/22,445/21728,0.3658508277203004,0.3713112878355288,0.18340875602345988,ADAMDEC1,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/22,446/21728,0.36650634065504417,0.3714725512330258,0.18348841188121595,STAT1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/22,463/21728,0.37755159040145203,0.3821496476593858,0.18876235058886073,ADAMDEC1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1/22,466/21728,0.3794815709423126,0.38319740341191877,0.1892798882600387,CXCL2,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/22,467/21728,0.3801236274487215,0.38319740341191877,0.1892798882600387,OAS2,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/22,467/21728,0.3801236274487215,0.38319740341191877,0.1892798882600387,IKBKE,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1/22,470/21728,0.38204599430604225,0.38461696331213946,0.1899810781347607,RSAD2,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,1/22,474/21728,0.38460029947588636,0.38666804302145563,0.19099420644600468,STAT1,1
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,1/22,480/21728,0.3884128687671996,0.38997694743337624,0.19262863572912337,LAG3,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,1/22,481/21728,0.3890461009249141,0.3900891199622463,0.19268404321242397,LAMP3,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/22,491/21728,0.39534409665080716,0.395873339082736,0.19554115116526924,SLC47A1,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,1/22,500/21728,0.4009592655865253,0.4009592655865253,0.19805333833502728,SAMD9,1
